Digestive System

The digestive system is the set of organs that takes in food, breaks it into molecules small enough to cross cell membranes, absorbs the useful products, and eliminates what remains. In humans it comprises the alimentary canal, a continuous tube from the mouth to the anus, together with accessory organs such as the salivary glands, pancreas, liver and gallbladder. Its work depends on mechanical breakdown, secretion of enzymes and acids, coordinated muscular movement, and absorption across a large epithelial surface. The system supplies the body with water, carbohydrates, proteins, lipids, vitamins and minerals, and it is closely linked to metabolism, homeostasis and the immune-system. Because it interacts with trillions of microorganisms and with the peripheral nervous system, it is also a major subject of medical and biological research.

This entry first defines the anatomical scope of the system and its general physiological functions, then describes the wall structure shared along the tract. It next follows the path of food region by region, from the mouth through the stomach, small intestine, large intestine and rectum, and covers the liver, gallbladder and pancreas as accessory organs. The later sections cover the control of motility and secretion, the chemical digestion and absorption of each class of nutrient, the gut microbiota, the immune barrier, embryonic development and comparative anatomy, the history of research, and the major disorders, diagnostic methods and treatments. The entry closes with unresolved questions, especially about the gut–nervous system interactions.

Anatomical Scope and Organization

The alimentary canal, also called the gastrointestinal tract, is a continuous muscular tube that runs from the mouth to the anus. Its organs lie in sequence: mouth, pharynx, esophagus, stomach, small intestine (duodenum, jejunum and ileum), large intestine (cecum and colon), rectum and anal canal. Each segment has a specialized role in digestion, and the lumen remains open from one end to the other, so ingested material passes through in one direction.

Four major accessory organs (the salivary glands, liver, gallbladder and pancreas) sit outside this tube. They are not part of its wall, but they deliver secretions into it through ducts. Saliva enters the mouth, while bile and pancreatic juice reach the duodenum. This separation matters anatomically, since disease in an accessory organ can affect digestion without any abnormality in the tube itself.

The biliary system and the pancreatic junction

The biliary system is a functional grouping rather than a single organ. The liver produces bile, the gallbladder stores and concentrates it, and the bile ducts carry it toward the intestine. In most people, the distal common bile duct and the main pancreatic duct join and form a true ampulla while traveling through the duodenal wall. This shared channel, the ampulla of Vater, opens at the major duodenal papilla, a slight elevation on the duodenal mucosa located in the second part of the duodenum, 7–10 cm distal to the pylorus. A sphincter of Oddi surrounds the junction and controls the flow of bile and pancreatic fluid from the liver and pancreas. Because the two ducts can be regulated separately by their own sphincters in some cases, the flow of bile and pancreatic juice is not always simultaneous.

Dimensions and the main site of absorption

The two intestines are named for their calibre rather than their length. The small intestine is longer: the average length of the small intestine in an adult human male is 6.9 m (22 feet, 6 inches), and in the adult female 7.1 m (23 feet, 4 inches). Its name comes from the fact that its lumen diameter is smaller than that of the large intestine. A morphometric study reports that the inner diameter of the small intestine averages 2.5 cm and that of the large intestine averages 4.8 cm. The large intestine is comparatively short, measuring around 5 ft long.

The small intestine is the principal site of absorption because its internal surface is greatly enlarged. Circular folds, villi and microvilli together amplify the small intestinal surface area by 60-120 times, and the total mucosal surface of the digestive tract is estimated at about 32 m², most of it in the small bowel. The colonic mucosa has far less amplification, and its main job is the reabsorption of water and electrolytes rather than the uptake of most nutrients. Accordingly, the small intestine is where almost all of the digestion and absorption of nutrients and minerals takes place, while the colon handles the final stages and the bacterial processing described in later sections.

Several anatomical landmarks help distinguish the segments. The duodenum is the shortest part of the small bowel, and it is the first region to receive chyme from the stomach. The jejunum and ileum form the rest of the small intestine, and their boundary is gradual rather than sharply marked. Their detailed structure, the wall layers and the regulation of transit are treated in later sections.

Physiological Functions

The digestive system carries out six core processes: ingestion, propulsion, mechanical digestion, chemical digestion, absorption and defecation. Ingestion is the intake of food and drink through the mouth. Propulsion moves contents along the tract by voluntary swallowing and involuntary peristalsis. Mechanical digestion breaks food into smaller pieces through chewing, churning in the stomach and segmentation in the intestine, which increases the surface available to enzymes. Chemical digestion uses enzymes and acid to split large molecules into absorbable units, a process described in detail under digestion. Absorption moves these products, together with water, electrolytes and vitamins, across the epithelium into the blood and lymph, and most of it occurs in the small intestine. Defecation removes what has not been absorbed. These processes overlap in space and time rather than running one after another.

Secretion and the daily fluid budget

Fluid handling is one of the least visible yet largest functions of the tract. An adult takes in roughly 1 to 2 liters of fluid with food and drink, but the tract processes about 9 liters per day in total. Estimates range from about 7 to 10 liters depending on the source. Most of this volume is secreted by the digestive glands and the intestinal wall itself. Textbook figures for individual contributions include about 1.5 liters from saliva, 2 liters of gastric secretion, 2 liters of pancreatic juice, about 0.5 liter of bile and about 1 liter of intestinal secretion, although these numbers vary between references.

Secretions are not simply water. They contain electrolytes such as sodium, chloride, potassium and bicarbonate, along with enzymes, mucus and, in the stomach, hydrochloric acid that brings the ph down to very low values. Pancreatic and duodenal bicarbonate secretion then neutralizes this acid before the chyme passes further along the intestine. The gut thus secretes acid and alkali in sequence, each serving a different stage of digestion.

Daily balance depends on reabsorption matching secretion. The small intestine recovers about 90 percent of the water that reaches it, roughly 8 to 8.5 liters per day, largely by osmosis that follows absorbed solutes. The colon recovers most of the remainder, and only about 100 to 200 milliliters per day normally leaves in the feces. Both segments have considerable reserve capacity. When that capacity is overwhelmed, the result is diarrhea. Cholera is the classic example: a bacterial toxin drives chloride secretion so strongly that several liters of watery stool may be lost each day, leading to rapid dehydration.

Fluid, electrolyte and acid-base regulation

Because water follows solutes, the transport of ions by the gut is central to whole-body fluid balance. Sodium is absorbed across the epithelium, often coupled to the uptake of glucose or amino-acids, and water follows it passively. The gut also absorbs potassium, calcium, magnesium and phosphate, and exchanges chloride and bicarbonate in ways that help set local acid-base conditions. When this regulation fails, as in persistent vomiting, diarrhea or malabsorption, the body loses fluid and electrolytes faster than it can replace them, and the kidneys must work to compensate.

Elimination of metabolic waste

The digestive tract also serves as an excretory route. The liver secretes bile containing bilirubin, a breakdown product of heme from aged red blood cells, together with cholesterol. Bile carries these substances into the intestine, where they are eliminated in the feces unless reabsorbed. Some drugs and toxins follow the same route. Much of the solid material in feces consists of undigested fiber, bacterial biomass and sloughed epithelial cells, and the stool is mostly water.

Integration with the rest of the body

The digestive system is tightly linked to the rest of the body. Its blood supply rises after a meal, and nutrient-rich venous blood drains through the hepatic portal system to the liver before reaching the general circulation. Enteroendocrine cells release hormones, including gastrin, cholecystokinin, secretin, GIP, GLP-1 and ghrelin, which regulate secretion, gastric emptying and gallbladder contraction, and which also act on the pancreas and on the brain to influence appetite and insulin release.

Nerves provide the second layer of control. The enteric-nervous-system, a network of neurons within the gut wall, coordinates peristalsis and secretion and responds to nutrients, pH and stretch. It is supplemented by the autonomic nervous system. Parasympathetic, largely vagal, input promotes secretion and motility, while sympathetic activation during stress reduces blood flow, motility and secretion. The cephalic phase shows how the system anticipates food: sight, smell and taste begin gastric and pancreatic secretion before anything reaches the stomach. Gut microbes add another regulatory input, since their fermentation products influence hormone release from enteroendocrine cells.

Wall Structure and Peritoneal Organization

Four layers of the wall

Along most of its length, the alimentary canal is built from four concentric layers. Counting from the lumen outward, these are the mucosa, submucosa, muscularis externa, and an outer serosa or adventitia the wall of the alimentary canal shows four distinct layers (from the lumen moving out): mucosa, submucosa, muscularis externa, and either a serous membrane or an adventitia. The mucosa is the innermost layer and is the part that contacts chyme directly The mucosa is the innermost layer of the gastrointestinal tract. It surrounds the lumen of the tract and comes into direct contact with digested food. Its epithelium, lamina propria and thin muscularis mucosae allow both secretion and local movement of the wall the most inner layer is the mucosa, formed by the epithelium, lamina propria, and muscularis mucosae. Mucus production is so characteristic of the gut epithelium that the layer is often described as a mucous membrane The mucosa is referred to as a mucous membrane, because mucus production is a characteristic feature of gut epithelium.

The submucosa is a connective-tissue layer that links the mucosa to the muscle. It holds blood and lymphatic vessels that carry away absorbed nutrients, along with submucosal glands that release secretions Positioned between the muscularis mucosa and the muscularis, it contains blood and lymphatic vessels that transport absorbed nutrients, along with scattered submucosal glands that release digestive secretions. It also contains the submucosal (Meissner's) plexus of the enteric nervous system The submucosa further supports the mucosa and also contains loose connective tissue, glands, blood vessels, nerve endings, and bundles of nerves called Meissner's plexus.

The muscularis externa generates mixing and propulsion. Its inner circular and outer longitudinal smooth-muscle layers do this work followed by the muscularis with its inner circular and outer longitudinal smooth-muscle layers that drive mixing and propulsion. The myenteric (Auerbach's) plexus lies between these sheets Interspersed between the muscle fibers is the plexus of Auerbach.. There are exceptions to the smooth-muscle pattern. In the mouth, pharynx and upper esophagus, the muscle is skeletal, which allows voluntary swallowing, and the external anal sphincter is also skeletal muscle In the mouth, pharynx, and superior and middle esophagus, the muscularis externa contains skeletal muscle that we use for voluntary swallowing. The external anal sphincter is also made of skeletal muscle, giving us voluntary control of defecation. The stomach adds a third muscle orientation, an oblique layer, that supports its churning The smooth muscle of the stomach is equipped for its churning function by the addition of a third layer, the oblique muscle.

The outermost layer depends on position. Organs that lie within the peritoneal cavity and move freely are wrapped in serosa, whereas fixed structures lying behind the peritoneum have adventitia Organs that are intraperitoneal and move freely have serosa, whereas fixed structures that are retroperitoneal have adventitia. The serosa consists of mesothelium, a simple squamous epithelium, over connective tissue Serosa consists of mesothelium, a specialised simple squamous epithelium, overlying connective tissue.

Regional differences

The same four-layer plan is modified to suit each segment. The stomach mucosa is organized into gastric pits and glands, which contain parietal, chief and enteroendocrine cells Gastric pits: surface mucous cells Gastric glands: parietal, chief, enteroendocrine cells. The large intestine's mucosa is simple columnar epithelium with goblet cells This is distinct from the mucosal lining of the colon, which is simple columnar epithelium with goblet cells.. Beyond these sources, the general pattern is that the small intestine carries circular folds and villi that enlarge its absorptive area, whereas the colon lacks villi and instead has crypts, and its outer wall is gathered into haustra. The esophagus has a non-keratinized stratified squamous lining rather than a glandular mucosa of the stomach type.

The peritoneum and its folds

The peritoneum is a serous membrane with two parts: a parietal layer lining the abdominal and pelvic walls and a visceral layer covering the organs, with a peritoneal cavity between them Your peritoneum is a membrane that lines the inside of your abdomen and pelvis (parietal layer). It also covers many of your organs inside (visceral layer). The space in between these layers is called your peritoneal cavity. Where the visceral layer folds back on itself, it forms a double sheet that carries structures to the organs. The mesentery is such a double layer of visceral peritoneum attached to the gastrointestinal tract, and blood vessels and nerves run between its two layers The mesentery is a double layer of visceral peritoneum that attaches to the gastrointestinal tract. There are often blood vessels, nerves, and other structures between these layers.

The mesentery of the small intestine suspends the bowel from the posterior abdominal wall, while still allowing it to move Suspends the small and large intestine from the posterior abdominal wall; anchoring them in place, whilst still allowing some movement.. The name changes with the segment: the peritoneal reflection to the jejunum and ileum is the mesentery, while the reflections to the colon are called mesocolons The peritoneal reflection to the jejunum and ileum is termed the mesentery, whereas those to the colon are each known as a mesocolon.. The lesser omentum runs from the stomach and first part of the duodenum to the liver and carries vessels and bile ducts The lesser omentum connects the stomach and the first part of the duodenum to the liver. It contains important blood vessels and bile ducts, aiding in digestion and nutrient absorption.. Most of the stomach and intestine is tethered to the body wall by mesentery, whereas organs such as the kidneys are retroperitoneal Most of the stomach and intestine is anchored to the body wall by peritoneal mesentery, whereas the three paired glands (kidneys, suprarenals, and gonads before birth) lie retroperitoneally.

Arterial supply

Three large midline arteries supply the gut. The celiac trunk serves the foregut, the superior mesenteric artery serves the midgut, and the inferior mesenteric artery serves the hindgut The celiac trunk supplies the foregut, superior mesenteric artery supplies the midgut and the inferior mesenteric artery supplies the hindgut.. The celiac trunk leaves the aorta at about the twelfth thoracic vertebra and divides into left gastric, common hepatic and splenic branches It arises from the abdominal aorta at the level of the twelfth thoracic vertebrae. It gives off three major branches, the left gastric, common hepatic and splenic arteries.. The superior mesenteric artery feeds the small intestine and the proximal colon, while the inferior mesenteric artery feeds the distal colon and rectum the SMA, which supplies the small intestine and proximal middle colon; and (3) the inferior mesenteric artery (IMA), which supplies the distal colon and the rectum.. The inferior mesenteric artery begins at about the level of the third lumbar vertebra The third, the inferior mesenteric artery, arises from the anterior wall of the aorta at the level of the third lumbar vertebra.

The territories are linked by collateral pathways. The pancreaticoduodenal arcade connects the celiac and superior mesenteric circulations The pancreaticoduodenal arcade connects the celiac and superior mesenteric circulations.. Because of these links, ischemia in these regions is uncommon, although the anastomoses are not unlimited.

Venous drainage and the hepatic portal system

The veins that drain the gut run alongside the major arteries and converge on the portal vein, which delivers blood into the liver as a single inflow tract The veins that drain the gastrointestinal organs parallel the major arteries that supply the foregut, midgut, and hindgut, including the celiac, superior mesenteric, and the inferior mesenteric arteries respectively. These veins eventually convene at the portal vein, forming a single venous inflow tract into the liver.. The hepatic portal vein collects blood from the stomach, intestines, pancreas and spleen, and it forms behind the neck of the pancreas where the superior mesenteric and splenic veins meet The hepatic portal vein is a vein that receives all the venous blood from the stomach, small and large intestines, pancreas and spleen. It arises at the confluence of the superior mesenteric and splenic veins, just posterior to the neck of the pancreas.. It enters the liver through the porta hepatis together with the hepatic artery and bile duct It passes through the porta hepatis together with the hepatic artery and bile duct as it enters the liver.. The liver receives roughly a quarter of cardiac output The liver receives 25% of the total cardiac output during each cardiac cycle.. The portal system also communicates with systemic veins, and these connections can provide an alternative route when portal flow is obstructed The portal system does have several anastomoses with the systemic venous system, which can compensate for obstructed portal venous return.

Mouth, Pharynx and Esophagus

Oral processing and the bolus

Digestion begins mechanically in the oral cavity. Chewing breaks food into smaller pieces while the food is mixed with saliva, so that a cohesive mass of suitable size and consistency forms before swallowing. The oral preparatory phase includes chewing and masticating, the mixing of food with saliva, and the formation of a bolus of suitable size and consistency. The tongue then contributes to shaping this mass. After the bolus is formed, the tongue creates a cup on its dorsal surface that entraps the bolus between it and the palate. The food bolus is therefore held in the mouth until the swallowing reflex is triggered.

Saliva: secretion, enzymes and volume

Saliva comes from three pairs of major glands, the parotid, submandibular and sublingual glands, together with many minor glands in the oral lining. The parotid glands produce a purely serous secretion, which is watery and rich in enzymes, particularly amylase. The submandibular glands produce a mixed serous and mucous secretion and are responsible for the majority of resting salivary flow. In contrast, the sublingual glands produce a predominantly mucous secretion, which is viscous and mucus-rich.

The two principal digestive enzymes are salivary α-amylase and lingual lipase. Amylase breaks down carbohydrates (starch) to maltose by cleaving the α-1,4 glycoside bindings. Lingual lipase is produced by serous glands at the back of the tongue and breaks down a small fraction of dietary triglycerides in the oral cavity and stomach. Its activity is unusual for a digestive enzyme in that it tolerates acid: lingual lipase and gastric lipase are both acid-stable, with pH optima around 4.0. This allows it to keep working after food leaves the mouth. Because amylase is a digestive enzyme that acts on starch rather than fat, the two enzymes divide the early work between them, while most lipid and starch digestion is completed later by pancreatic enzymes.

Estimates of daily saliva output vary. One review states that the total volume of saliva produced is 750–1000 ml daily which is contributed by major and minor salivary glands, whereas another source estimates that humans normally produce around 500 ml of saliva per day. Resting flow is much lower, 0.2–0.4 ml/min. Saliva also contributes mucins that lubricate the bolus, and salivary mucins form a lubricating barrier which protect the oral mucosa from mechanical trauma and toxins.

The three phases of swallowing

Swallowing is conventionally divided into oral, pharyngeal and esophageal phases, and the first is under conscious control. The initial stage of deglutition, the oral phase, is voluntary and triggers the subsequent involuntary pharyngeal and esophageal phases. In the oral phase, the tongue moves the bolus toward the back of the mouth. The pharyngeal phase starts when the bolus reaches the anterior tonsillar pillars, a step that depends on sensory input carried by the glossopharyngeal and vagus nerves. Once initiated, the remainder of the phase is involuntary and completed in approximately 1 second.

During this brief phase the airway is protected. During the pharyngeal phase, the tongue seals the oropharynx. The soft palate and proximal pharyngeal wall seal off the nasopharynx. The vocal cords and arytenoids close off the laryngeal opening and the epiglottis swings down to cover the laryngeal vestibule. The upper esophageal sphincter then relaxes so that the bolus can enter the esophagus. The coordinated action involves several cranial nerves; one source lists five cranial nerves (V, VII, IX, X, and XII) and 26 muscle groups, while another gives a different count of muscles, so such figures should be read as approximate.

The esophageal phase is also involuntary. Movement along the esophagus is driven by peristalsis, which is primarily controlled by the autonomic nervous system.

Upper and lower esophageal sphincters and peristalsis

The esophagus has two functional sphincters. The upper esophageal sphincter (UES) is a high-pressure zone at the transition of the pharynx and the cervical esophagus. Its closing muscles are the cervical esophagus, cricopharyngeus, and inferior pharyngeal constrictor, but primarily the cricopharyngeus. The UES is normally closed and opens during swallowing; with normal swallowing, the UES opens only when a person is swallowing food and otherwise remains closed. Its closure also guards against reflux into the throat and against air entering the esophagus during inspiration.

The lower esophageal sphincter (LES) lies where the esophagus meets the stomach. Its intrinsic component is smooth muscle that stays tonically contracted, and direct inhibitory signals allow the smooth muscles in the LES to relax, opening the sphincter and enabling the passage of a food bolus. The LES relaxes soon after a swallow begins and remains relaxed until the peristaltic wave arrives.

Peristalsis is the wave of propulsion that carries the bolus. This occurs through sequential or "peristaltic" contraction of circular muscle in the esophageal body, in concert with appropriately timed relaxation of the upper and lower esophageal sphincters. The wave is organized centrally by vagal motor neurons, which project onto inhibitory and excitatory neurons in the esophageal myenteric plexus. The distal half to two-thirds of the esophageal body, together with the LES, is smooth muscle, while the upper part is striated. Transit is rapid, roughly 3–5 cm per second, so a bolus typically reaches the stomach within about nine seconds.

Stomach

Anatomy and regions

The stomach is a J-shaped, muscular sac between the esophagus and the duodenum, lying mainly in the upper left abdomen. Its anatomy is usually described in four regions. The cardia surrounds the opening from the esophagus. The fundus is the dome that rises above that opening. The body (corpus) is the large central portion, where most secretion occurs. The pylorus, which includes the antrum and the pyloric canal, ends at the pyloric sphincter, which controls passage into the duodenum. The lesser curvature runs along the medial border and the greater curvature along the lateral border.

Gastric glands and cell types

The mucosa is organized into gastric pits that open into tubular glands, and the cell composition of these glands varies by region. The oxyntic (fundic) glands of the body and fundus contain parietal cells, which secrete hydrochloric acid and intrinsic factor; chief cells, which secrete pepsinogen and gastric lipase; enterochromaffin-like cells, which release histamine; and mucous neck cells. The pyloric glands of the antrum contain G cells, which secrete gastrin, D cells, which secrete somatostatin, and mucous cells. Glands near the cardia are dominated by mucus-secreting cells.

Acid, enzymes and intrinsic factor

Parietal cells use a proton pump (H⁺/K⁺-ATPase) to move hydrogen ions into the lumen, so that gastric contents can fall to a pH of roughly 1 to 2 when the stomach is empty. The stomach secretes on the order of 1.5 to 3 liters of gastric juice per day. Acid converts pepsinogen into pepsin, and the activation is self-amplifying, since pepsin can also activate further pepsinogen. Pepsin, which cleaves peptide bonds through hydrolysis, works best near pH 2. Acid also denatures dietary proteins, exposing them to enzymes, and it kills many ingested microorganisms. Intrinsic factor, a glycoprotein, binds vitamin B12 and allows its absorption in the terminal ileum. Loss of parietal cells, as in autoimmune gastritis, can therefore cause pernicious anemia. Gastric lipase from chief cells begins the breakdown of triglycerides, a step that is especially important in infancy.

Mucosal protection

The surface epithelium is shielded by a thick layer of mucus rich in glycoproteins called mucins. Bicarbonate is secreted into this layer, so that the pH at the epithelial surface stays close to neutral even though the lumen is strongly acidic. Tight junctions between epithelial cells limit the back-diffusion of acid into the tissue, and prostaglandins support both mucus and bicarbonate secretion as well as mucosal blood flow. Surface cells are replaced every few days. When this defense weakens, damage follows. Non-steroidal anti-inflammatory drugs reduce prostaglandin production, while Helicobacter pylori colonizes the mucus layer and uses urease to raise the local pH, which can erode the barrier and lead to gastritis and ulceration.

Mixing, chyme formation and emptying

The stomach stores food and carries out much of its mechanical digestion. Its muscularis externa has three layers, an outer longitudinal, a middle circular and an inner oblique layer. On swallowing, the fundus relaxes to accommodate the meal without a large rise in pressure. Peristaltic waves then move through the body and antrum, churning the contents into a semifluid mixture called chyme. Each wave pushes chyme toward the pylorus, and the partially closed pylorus returns much of the material back into the stomach for further mixing.

Emptying is regulated so that the duodenum receives material it can process. Liquids and carbohydrates leave the stomach faster than protein and fat. Gastrin from G cells, released in response to peptides and amino acids, stimulates acid secretion and gastric motility, while somatostatin dampens them. In the duodenum, low pH, fatty acids, amino acids and high osmolarity trigger hormonal feedback through secretin, cholecystokinin and related signals, together with neural enterogastric reflexes, which slow gastric emptying. The result is that chyme enters the small intestine in measured portions rather than in one surge.

Small Intestine

The small intestine is the longest segment of the tract, typically about 3 to 5 meters in a living adult, running from the pylorus to the ileocecal junction. Its three segments differ in size, position and specialization, but together they carry out most of the digestive work and nearly all nutrient uptake.

Duodenum

The duodenum is the shortest and widest segment. It is the widest, shortest, and least mobile of the three segments of the small intestine. Most of it lies behind the peritoneum, so it is fixed in place, whereas the jejunum and ileum hang from a mesentery and move more freely. The C-shaped loop wraps around the head of the pancreas, and it connects to ducts from the gallbladder and pancreas. Its wall contains Brunner's glands, which are found in the duodenum but not in other parts of the small intestine. Here chyme from the stomach is neutralized and mixed with secretions, and its primary function is to initiate the absorption of nutrients from food.

Jejunum

The jejunum is the middle segment, measuring around 2.5 meters. Its mucosa carries circular folds and intestinal villi that increase its surface area. It is the principal site for taking up the simple products of digestion. Products of digestion (sugars, amino acids, and fatty acids) are absorbed into the bloodstream here. Most of the carbohydrate and protein breakdown products therefore leave the lumen in this region.

Ileum

The ileum is the final and longest-lived segment of absorption, about 3.5 metres (11.5 feet) long in some reference measurements, though other sources give a range of 2 to 4 meters. It ends at the ileocecal valve. Its villi resemble those of the jejunum, but it has specialized uptake functions that the upper segments do not. Its main job is to absorb vitamin B12 and bile acids, as well as any other remaining nutrients.

Vitamin B12 uptake depends on intrinsic factor. Vitamin B12, or cobalamin, is absorbed in the terminal ileum, and requires intrinsic factor for absorption. Deficiency can progress to anemia and nervous system damage (macrocytic anemia, along with severe nervous system impairment).

Bile salts are the other key cargo. Bile acids released into the duodenum are recovered in the distal ileum and sent back to the liver, which is the only site for this reabsorption. One source reports that about 95% of bile acids are reabsorbed by active transport in the ileum, while another states that loss of the distal ileum removes a segment where 90% or more of bile salts are reabsorbed. The exact figure differs between sources, but the ileum's dominant role is not in doubt. When this recovery fails, they continue on in your gut into the colon, where they draw a lot of water into the bowel, which produces diarrhea. Surgical removal of ileum can cause malabsorption of essential nutrients such as vitamin B12 and bile acids.

Villi, microvilli and the brush border

The small intestine's large absorptive area comes from three levels of folding. These two activities are facilitated by structural adaptations that increase the mucosal surface area by 600-fold, including circular folds, villi, and microvilli. Published estimates vary considerably; one textbook figure gives a total surface of approximately 200m2. Villi are themselves densely packed, with about 20 to 40 villi per square millimeter, and the microvilli on their epithelial cells form a dense layer, with an estimated 200 million microvilli per square millimeter of small intestine.

The microvillous surface is also a site of chemistry. The absorptive cells synthesize digestive enzymes and then place them in the plasma membranes of the microvilli. As a result, enzymatic digestion occurs not only in the lumen, but also on the luminal surfaces of the mucosal cells. The principal brush border enzymes include sucrase-isomaltase, lactase, maltase-glucoamylase, and trehalase, which convert disaccharides into monosaccharides such as glucose. Brush border peptidases complete protein breakdown, releasing amino acids and small peptides from the chyme.

Overall role

The small intestine is where digestion is completed and virtually all absorption occurs. A single meal can pass through its full length in up to 5 hours, during which it absorbs the great majority of nutrients. It also extracts excess water and sends the remaining food waste to the large intestine to form stool.

Liver and Biliary System

Bile is made continuously in the liver, which is the source of the fluid that carries cholesterol derivatives and waste products into the intestine. Within each hepatic lobule, hepatocytes assemble bile while blood flows past them in the opposite direction. Adults produce roughly 400 to 800 mL a day, according to one common estimate, and some sources put the figure near 1 L.

Composition and synthesis

Water makes up about 95 percent of bile. Bile salts are the largest dissolved organic component, and they account for about two-thirds of the solids. Phospholipids, cholesterol, conjugated bilirubin, and inorganic electrolytes make up most of the rest. Bilirubin is a breakdown product of haemoglobin that the liver conjugates before excretion, so it gives bile its color.

Hepatocytes convert cholesterol into primary bile acids, cholic acid and chenodeoxycholic acid, using a cascade of enzymes that begins with 7α-hydroxylase. Attaching glycine or taurine to these acids produces bile salts, which are more water-soluble and therefore work better as detergents. Bacteria in the lower small intestine and colon later modify some of these molecules into secondary bile acids, which broadens the pool. The canalicular bile salt export pump, encoded by ABCB11, is the main driving force that moves bile salts into the bile canaliculi. Bile then leaves the lobule in two stages. Hepatic bile enters the ducts first, and ductal cells add a watery, bicarbonate-rich fluid as it flows toward the gallbladder or duodenum.

Storage, concentration and release

Between meals, the flow of bile is low, and most of it is diverted into the gallbladder, where it is concentrated roughly fivefold. When chyme reaches the small intestine, the signals that trigger bile release come mainly from hormones. Fat in the duodenum is the most potent stimulus for cholecystokinin (CCK) secretion. CCK contracts the gallbladder and relaxes the sphincter of Oddi, which allows bile to pass into the duodenum. In one controlled study of healthy volunteers, a meal containing 25 g of triglyceride produced the highest CCK release and the greatest gallbladder contraction, whereas low-fat meals produced much weaker responses. Bile acids in turn feed back on the gallbladder through the receptors TGR5 and FXR, which partly counteract CCK-mediated contraction.

Once in the duodenum, bile salts act as detergents. They emulsify dietary fat into small droplets, which increases the surface available to pancreatic lipases and supports the absorption of fat-soluble vitamins. Emulsification is therefore a step in digestion rather than a chemical reaction, since bile does not itself hydrolyse fats.

Enterohepatic circulation

Most bile acids are not lost. In the enterohepatic circulation, roughly 95 percent are reabsorbed in the terminal ileum, mostly by an active sodium-dependent transporter, and the remainder passes into the colon. Blood from the ileum enters the portal vein, and hepatocytes extract most of the returning acids in a single pass; one estimate puts this first-pass uptake at 75 to 90 percent. The cycle is repeated several times during each day, and the circulating bile acid pool is maintained at about 3 to 5 g by this recycling together with de novo synthesis. Daily fecal loss is small, typically 0.2 to 0.6 g, and it is replaced by new synthesis from cholesterol. The circulation is central to fat digestion and to whole-body cholesterol regulation, and it is also the mechanism by which the body conserves bile salts rather than producing them continuously from scratch.

Functions beyond digestion

The liver performs many roles that are unrelated to bile. Hepatocytes carry out detoxification by using cytochrome P450 and related enzyme systems to modify drugs, toxins and metabolic by-products, and they convert ammonia into urea so that it can be excreted. The liver stores glycogen and releases glucose into the blood through glycogenolysis and gluconeogenesis, which helps maintain blood glucose between meals. It also synthesizes most plasma proteins, including albumin and many clotting factors, which links its metabolic work to the protein economy of the whole body.

Pancreas

The pancreas is a retroperitoneal gland that lies behind the stomach. It has two functional parts with different roles. The exocrine pancreas, which makes up most of the organ, secretes digestive enzymes and bicarbonate-rich fluid into the duodenum. The endocrine pancreas, the islets of Langerhans, releases hormones directly into the blood.

Exocrine acinar cells and digestive enzymes

Exocrine tissue is organized into acini, small clusters of acinar cells whose apical surfaces face a central lumen. Acinar cells store their secretory products in zymogen granules, membrane-bound packets that release their contents into the duct system when the cell is stimulated. Acetylcholine and cholecystokinin are among the secretagogues that trigger this fusion. Digestive enzymes make up about 90% of the protein in pancreatic secretions, and trypsin is the most important of them. The acinar cells synthesize a mixture of roughly twenty enzymes and isoenzymes, including amylase, lipases, several proteases, carboxypeptidases, esterases, ribonucleases and deoxyribonucleases. Most of the proteases are made as inactive precursors called zymogens. Pancreatic amylase and lipase, by contrast, are secreted in active form. Because the pancreas makes most of its proteolytic enzymes as zymogens, the cells can store large amounts of protein-digesting capacity without digesting themselves.

Activation of trypsinogen in the duodenum

Activation happens only after the secretion reaches the small intestine. Enteropeptidase, formerly called enterokinase, sits in the brush border membrane of duodenal enterocytes and cleaves trypsinogen to trypsin. Trypsin then converts the remaining trypsinogen to trypsin, which is an autocatalytic loop, and it also activates chymotrypsinogen and procarboxypeptidases. Acinar cells also secrete a trypsin inhibitor that restrains any premature activation inside the gland and its ducts. Acute pancreatitis is understood as a failure of this protection. When trypsin activity inside acinar cells exceeds the inhibitory capacity, activated enzymes are released into the gland, where they damage tissue and trigger inflammation. Calcium-dependent activation of acinar cells is also implicated in this process. Experimental work in rat acinar cells has also suggested that bicarbonate can reduce zymogen activation and early vacuole formation, pointing to a protective role for bicarbonate signaling within the cell.

Bicarbonate secretion from ductal cells

Duct cells add a large volume of alkaline fluid to the pancreatic juice. Bicarbonate is secreted into the lumen through a chloride-bicarbonate exchanger, and a CFTR chloride channel on the apical membrane allows chloride to recycle back into the duct. Carbonic anhydrase in the duct cells converts water and carbon dioxide into bicarbonate and hydrogen ions. In the duodenum, this bicarbonate neutralizes the acidic chyme that arrives from the stomach. Raising the pH to a near-neutral level allows the pancreatic and intestinal enzymes to work efficiently and protects the mucosa of the duodenum from acid. The volume and bicarbonate content of the secretion both increase in response to the hormone secretin and to vagal input, as well as to vasoactive intestinal peptide and gastrin-releasing peptide.

The endocrine islets

The islets of Langerhans make up only about 2% of the pancreatic mass, but they are central to the regulation of blood glucose. The islets contain several cell types. Beta cells secrete insulin, which lowers blood glucose, and alpha cells secrete glucagon, which raises it by stimulating the liver to break down glycogen and to release glucose. Delta cells secrete somatostatin, and a small number of PP cells secrete pancreatic polypeptide. Estimates of cell proportions vary. Some reviews place beta cells at 60–70% and alpha cells at 20–25% of the islet, while others report that human islets contain about 60% beta cells and 30% alpha cells, and that about half of human islets have few or no alpha cells. Human islets differ from those of rodents: in rodents beta cells form the core and alpha cells sit at the periphery, whereas in humans alpha and beta cells are closely intermixed throughout the cluster. Within the islet, beta cells are electrically coupled through gap junctions, which allows synchronized calcium oscillations and pulsatile insulin release. Insulin secretion depends on glucose entry through the GLUT-2 transporter and phosphorylation by glucokinase. Disruption of this system is central to diabetes. Islet hormones are secreted into the bloodstream rather than the gut lumen, so the endocrine and exocrine functions of the pancreas are structurally and functionally separate, even though they share one organ.

Large Intestine and Rectum

The large intestine starts at the cecum, a blind pouch that receives material from the ileum through the ileocecal valve. Chyme that has not been absorbed by the time it leaves the small intestine passes through the ileocecal valve and enters the large intestine at the caecum. The vermiform appendix hangs from this pouch. Beyond the cecum, the colon is organised into four named segments: ascending, transverse, descending and sigmoid. In adults the rectum is the last part of the tract before the anal canal. Anatomically, the ascending colon, descending colon and rectum are located in the retroperitoneum (outside the peritoneal cavity). The transverse and sigmoid segments instead hang from the posterior abdominal wall on a mesocolon, a peritoneal fold described in the section on the peritoneum.

The colon's characteristic appearance comes from its musculature. Three longitudinal bands of smooth muscle, the teniae coli, run along its length. These structures are formed by the contraction of the longitudinal muscle bands of the colon. The wall between the bands bulges outward into sacs called haustra. Their contractions are slow and rhythmic. The presence of food residues in the colon stimulates haustral contractions, which occur approximately every 30 minutes and last about one minute each. Each contraction pushes contents into the next segment, and the movement is not strictly forward. Intestinal content is pushed back and forth by haustral contractions and antiperistaltic contractions, until faeces are finally pushed towards the anal canal by mass movements.

The large intestine's main task is recovering water and salts from material the small intestine could not absorb. The small intestine already takes up most of the fluid, so the colon works on a much smaller load. The small intestine will have absorbed about 90% of the ingested water. The large intestine absorbs most of the remaining water, a process that converts liquid chyme residue into semi-solid stools or faeces. Estimates of daily absorption vary, but one commonly cited figure is about 1 L/day. Sodium and chloride are actively moved across the epithelium, and water follows osmotically. The colonic mucosa differs from that of the small intestine: it has no villi, and its surface is covered with straight crypts (crypts of Lieberkühn) that hold absorptive cells and abundant goblet cells, which secrete mucus to lubricate the intestinal walls, aiding faecal passage and nutrient absorption.

The colon also hosts a dense community of microorganisms. Bacteria carry out fermentation of undigested material, especially soluble dietary fiber and resistant starch. The products include short-chain fatty acids, which the colonic epithelium takes up and uses as an energy source. Absorption of bacterial products – absorbs short-chain fatty acids (SCFAs) produced by bacterial fermentation, which provide an important energy source for colonocytes. Water and electrolyte handling by the colon is an important part of whole-body homeostasis. Transit is slow by comparison with the upper tract. Meals pass from the small to the large intestine within 8-9 hours of ingestion. The slow passage allows time for absorption and for bacterial processing before the residue is eliminated.

Storage and Defecation

As the residue dries and compacts, it moves toward the rectum. Mass movements, which are strong peristaltic waves that sweep long stretches of colon at once, deliver faeces into the rectum. The rectum usually stays empty between these events because the angle where the sigmoid colon meets it helps hold stool back. When stool enters the rectum and stretches its wall, defecation begins. The process begins with mass movement from the colon to the rectum, initiating the defecation reflex, which involves rectal contraction and internal and external anal sphincter relaxation. Rectal stretch receptors signal the spinal cord, which relays the message to the brainstem and cortex, so the person becomes aware of the urge.

The defecation reflex has a feedback component. Once the internal sphincter begins to relax and the external sphincter starts to open, the stretch of the rectum increases, which intensifies parasympathetic output to the colon and rectum. An important feature of the defecation reflex is its positive feedback loop. This feedback continues until evacuation is complete.

Anal Canal and Sphincter Control

The anal canal is controlled by two sphincters with different types of muscle. The internal anal sphincter is a thickened continuation of the circular rectal muscle. The circular muscle layer of the rectum condenses approximately three-fold at the anus to form the internal anal sphincter. It is approximately 3 cm long and 3 mm wide, being slightly longer in men and getting thicker with age. Because it is smooth muscle, its tone is set by autonomic input and it works without conscious effort. Its reflex relaxation, known as the rectoanal inhibitory reflex, lets a small amount of rectal content enter the upper canal, where it can be sensed.

The external anal sphincter is skeletal muscle and can be controlled voluntarily. The external anal sphincter is made of skeletal muscle and is innervated by somatic motor fibers of the pudendal nerve, which also arises from the sacral plexus (S2–S4). Conscious control lets a person delay defecation by tightening the external sphincter and the puborectalis muscle, which straightens and holds the anorectal angle. During evacuation, the person voluntarily relaxes these muscles, the anorectal angle opens, and abdominal straining raises intra-abdominal pressure. Voluntary control of the external anal sphincter is key in the voluntary deferring of evacuation until a socially opportune moment. Young children have not yet acquired this control and rely on the reflex. Voluntary control is learned, typically through toilet training.

Motility and Transit

Patterns of contraction

In the fed state, two patterns dominate. Segmentation involves multiple simultaneous rhythmic contractions of the circular muscle over discrete segments, and it moves the contents slowly towards the colon. Because the contractions push material in both directions, they mix intestinal contents with digestive juices and keep the chyme in contact with the absorptive lining to ensure maximal absorption of nutrients.

Peristalsis works differently. It is a wave that travels in one direction. The longitudinal muscle contracts to shorten the segment while the inner muscle layer in an adjacent region is relaxed, and the normal direction of flow is from mouth to anus. The wave is initiated by distension of the gut wall. The rhythm itself is generated within the wall by neuronal circuits, since peristalsis is controlled by rhythmic circuits in the enteric nervous system, and the myenteric plexus controls motor neurons innervating the longitudinal and circular muscle layers.

The migrating motor complex

When the gut is empty, the pattern changes. The migrating motor complex (MMC) sweeps the GI tract clean during periods of fasting. The complex was first characterized in fasting dogs in 1969 by Joseph Szurszewski at the Mayo Clinic, who also showed that this activity stops upon eating a meal. Its cycle length is reported differently across sources: one review gives rhythmic contractions around 90–120 minutes apart, another gives every 45–180 minutes during the interdigestive phase, and a general reference gives 1.5 to 2 hours.

The MMC usually starts in the stomach, although it can begin in either the duodenum or the jejunum. Its waves carry residue onward. These contractions sweep any undigested material, as well as some bacteria, sloughed cells and residual secretions, towards the colon. The complex is also thought to be a bacterial control mechanism: it prevents bacterial overgrowth due to stagnant food contents. Its timing is not fixed across the day, since the migrating motor complex has a circadian pattern with reduced propagation velocity and shorter duration, particularly of phase II, at night.

Sphincters and flow control

Sphincters are maintained by tonic contractions that are under hormonal and nervous control. A sphincter must relax before material can cross it, so to open the sphincter the muscle must relax. Among the key sites is the sphincter of Oddi, which controls the flow of bile and pancreatic juices into the duodenum from the liver, gallbladder, and pancreas.

The ileocecal junction shows how timing is coordinated. The valve is normally closed, and when motility in the ileum increases, this sphincter relaxes, allowing food residue to enter the first portion of the large intestine, the cecum. Hormones and reflexes drive this. Digestive activity in the stomach provokes the gastroileal reflex, which increases the force of ileal segmentation. The stomach releases the hormone gastrin, which enhances ileal motility, thus relaxing the ileocecal sphincter. In this way, gut motility is coordinated by the autonomic nervous system, hormones and other mechanisms intrinsic to the GI tract.

Factors that change transit time

Transit varies widely. In healthy adults, total gastrointestinal transit time, meaning the time from eating a meal to excreting it, ranges from approximately 24 to 72 hours. Gastric emptying is usually quicker than colonic transit, and the greatest variation occurs in the colon.

Meal composition is one of the strongest modifiers. Fat is widely reported to have the greatest effect on the rate of gastric emptying, possibly through the calorie density of fatty food together with hormone receptors that respond to fat. Fiber acts differently depending on its type: insoluble fiber acts like a broom, while soluble fiber forms a gel that slows emptying. Findings on high-fat diets are not uniform. In one small study, a 4-week intervention on a high-fat diet with 12 healthy men resulted in accelerated gastric emptying and orocaecal transit time when compared with a low-fat diet.

Physical activity is also associated with faster transit, though the effect depends on intensity. In one study, more time spent on physical activity at high light intensity was associated with more rapid colonic and whole gut transit time. For acute exercise, low to moderate intensity exercise of short duration appears to accelerate gastric emptying, whereas prolonged and vigorous intensity exercise slows gastric emptying during and after exercise. Some authors propose that exercise changes transit through a reduction in gastrointestinal blood flow, increased gastrointestinal motility, mechanical bouncing, and neuro-immuno-endocrine alterations.

Neural and Hormonal Regulation

The enteric nervous system

The gut has its own nervous system, the enteric nervous system (ENS), which is embedded in the wall of the tract. Published size estimates vary. One review puts the human ENS at about 200 million neurons, with three to five times as many enteric glial cells. Another gives approximately 400-600 million neurons, and an older textbook gives about 100 million. Its neurons sit in two ganglionated networks. The myenteric plexus lies between the muscle layers and is well positioned for its key role in coordinating gut movements. The submucosal plexus lies beneath the mucosal epithelium and is mainly involved in the control of water and electrolyte secretion, and blood flow. The ENS can operate independently of the brain and the spinal cord, although it also receives considerable autonomic innervation.

The three phases of gastric secretion

Gastric secretion is divided into cephalic, gastric and intestinal phases. These phases overlap in time and each responds to different stimuli. Once gastric secretion starts, all three phases can take place simultaneously.

The cephalic phase begins before food arrives. It occurs even before food enters the stomach, by the mere sight, smell, or taste of food. Vagal efferents then stimulate parietal cells to secrete hydrochloric acid and chief cells to release pepsinogen. The same vagal activation also drives pancreatic enzyme and hormone release. Its existence was established through "sham feeding" experiments, and a related study found that the cephalic insulin response is modest (about 25% above baseline) while the pancreatic polypeptide response roughly doubles, which makes it a sensitive marker of vagal activity. Estimates of how much acid this phase contributes differ: one textbook assigns about 40%, while another gives 30–40% to the gastric phase's share and 50–60% to the gastric phase.

The gastric phase starts when food enters the stomach. Distension of the stomach wall activates stretch receptors, and chemical stimuli such as peptides and amino acids activate chemoreceptors. During the gastric phase, the hormone gastrin is secreted by G cells in the stomach in response to the presence of proteins.

The intestinal phase begins when chyme enters the small intestine, and it mainly slows the stomach. Initially, this phase can stimulate gastric secretion via intestinal gastrin release, but predominantly it inhibits gastric secretion to regulate the rate of stomach emptying. This inhibition is mediated by hormones such as secretin, cholecystokinin (CCK), and gastric inhibitory peptide (GIP), as well as neural reflexes that reduce gastric motility and secretion.

Gut hormones and their targets

Enteroendocrine cells of the gut collectively secrete more than 30 different hormones. Five of them, gastrin, cholecystokinin (CCK), secretin, gastric inhibitory peptide (GIP), and motilin, act predominantly as endocrine signals in the blood. Several act in other ways too: gastrin, motilin and CCK function as endocrine- and neurocrine-type hormones, whereas gastrin and GIP are thought to act exclusively in an endocrine fashion.

• Gastrin is released from the gastric antral mucosa, particularly in response to a meal high in protein. It stimulates acid and pepsin secretion from the stomach, and it also promotes motility along the tract.
• Cholecystokinin is produced by enteroendocrine cells in the duodenum. Its major targets are the pancreas and gallbladder: it increases pancreatic enzyme output, including trypsinogen, lipases and nucleases, and it causes gallbladder contraction. In the stomach, CCK mainly acts as an inhibitor of acid secretion.
• Secretin is released from S cells in the duodenum and proximal jejunum in response to the presence of acidic pH in the lumen. It stimulates the pancreas to release water and bicarbonate, which neutralizes the acid, and it also slows gastric emptying.
• GIP is a 42-amino-acid peptide released from K cells in the duodenum and jejunum, with secretion triggered by glucose, amino acids and fatty acids. It inhibits gastric acid secretion and stimulates insulin release from the pancreatic islets in response to glucose.
• Ghrelin is secreted mainly by cells in the gastric fundus, and it is the only recognized appetite-stimulating hormone of the gut. Its level rises during fasting and before eating.

Gut hormones also link the digestive tract with the brain. This interaction is often called the brain-gut axis, and it contributes to signaling satiety.

Autonomic and vagal control

The autonomic nervous system adds a second layer of control. Parasympathetic input from the vagus nerve leads to parasympathetic stimulation via the vagus nerve, promoting secretion of gastric juices even before food enters the stomach. Vagal fibers also activate neurons in the gastrointestinal nervous plexus, which, in their turn, influence secretion and contractile functions. Sympathetic input generally has the opposite, inhibitory effect on motility and secretion. Vagal sensory fibers carry information from the gut back to the brainstem, which closes the loop between nerves, hormones and the central regulation of feeding.

Enzymatic Digestion of Macronutrients

Carbohydrates

Starch breakdown starts in the oral cavity, where saliva-borne amylase converts part of the polysaccharide into maltose. Amylase is largely shut down in the stomach: salivary amylase is inactivated by low gastric pH (below 4.0), so the bulk of starch digestion relies on pancreatic amylase in the duodenum. Amylases cannot cut every bond. They cannot cleave terminal α-1,4 bonds, α-1,6 branch points, or disaccharide bonds such as those in sucrose and lactose. Those remaining bonds are handled by brush border enzymes on the microvillous surface of the small intestinal epithelium. Sucrase-isomaltase is a single gene product with two active sites. Its sucrase site splits sucrose into glucose and fructose. Lactase splits lactose, found only in human milk or dairy products, into galactose and glucose. Maltase-glucoamylase cleaves the α(1,4)-glycosidic bond at the nonreducing end of oligosaccharides, releasing terminal glucose. The resulting monosaccharides are taken up by enterocytes through a sodium-dependent carrier, SGLT1, for glucose and galactose, while fructose crosses on GLUT5 by facilitated diffusion.

Proteins

Protein digestion begins in the stomach, where gastric pepsin, acting in acid, produces peptides of about four to nine amino acids from intact protein. In the duodenum, the pancreatic proteases are endopeptidases that catalyze the hydrolysis of peptide bonds inside the protein chain. They differ in specificity: trypsin acts on bonds next to basic residues, such as lysine and arginine, while chymotrypsin acts on bonds adjacent to aromatic residues, tyrosine, phenylalanine, and tryptophan. These enzymes are secreted as zymogens and must be activated. Enteropeptidase, a brush-border enzyme, converts trypsinogen to trypsin, and trypsin then converts the other zymogens to their active forms.

Final hydrolysis occurs at the brush border. Among the many peptidases bound there, aminopeptidase N is the most abundant and removes amino acids from the N-terminus of short polypeptides. Dipeptides and tripeptides are also transported into the enterocyte, where they are converted to amino acids by intracellular peptidases. Transport of free amino acids and peptides is discussed in the absorption section of this article.

Lipids

Fat digestion depends on the interaction of bile, pancreatic lipase and colipase. Intact triglyceride droplets covered with bile salts are not accessible to pancreatic lipase. Emulsification uses bile salts to break large lipid droplets into smaller particles, increasing the surface area available to lipase. Pancreatic lipase then acts on the emulsified surface. It preferentially cleaves the sn-1 and sn-3 fatty acids of triglycerides, forming a 2-monoglyceride and two free fatty acids. Colipase is essential because it eliminates the inhibitory effect of physiologic concentrations of bile acid salts on the activity of lipase. The cofactor is secreted as procolipase, and it is activated by trypsin.

The lipolysis products do not stay free in solution. Fatty acids and monoglycerides, together with bile acids and phospholipids, form micelles spontaneously. These mixed micelles carry the lipid products to the brush border, and they also contain monoglycerides, free fatty acids, cholesterol, and fat-soluble vitamins.

Nucleic Acids

Dietary nucleic acids are digested in a sequence of hydrolytic steps. Pancreatic juice contains ribonuclease and deoxyribonuclease, which cleave RNA and DNA into shorter oligonucleotides. Intestinal nucleotidases and phosphatases then remove phosphate groups to release nucleosides, and nucleosidases and related enzymes split these into free purine and pyrimidine bases and sugars. Nucleosides and bases are absorbed through specific membrane transporters. Unlike the other macronutrient classes, the end products of nucleic acid digestion are small enough to be absorbed without further processing, and much of their subsequent fate is determined in other tissues.

Absorption and Transport

Absorption is the passage of digested nutrients, electrolytes and water from the lumen of the intestine into the blood or lymph. Most of it occurs across the single layer of epithelial cells lining the small intestine, and the cells doing the work are enterocytes (absorptive epithelial cells). Each nutrient class uses its own route, but most movements fall into three broad mechanisms: passive diffusion, facilitated diffusion through carrier proteins, and active transport that spends energy, often by coupling to the sodium gradient. Nutrients then leave the enterocyte on its basolateral side and enter one of two circulations: capillaries that drain to the liver, or lacteals that drain to the lymphatic system.

Carbohydrates and Glucose

Monosaccharides are the main carbohydrate products absorbed. Glucose and galactose enter the enterocyte at the apical (brush border) membrane through SGLT1, the sodium-glucose cotransporter. SGLT1 moves two sodium ions together with one glucose molecule, so its driving force comes from the sodium gradient that the basolateral Na⁺/K⁺ pump maintains. Glucose then leaves the cell across the basolateral membrane through GLUT2, a facilitated-diffusion transporter. Fructose uses a different pathway: GLUT5 carries it across the apical membrane by facilitated diffusion. Classical work showed that SGLT1 saturates at a luminal glucose concentration of about 30 mmol/L, yet glucose absorption continues to rise at higher concentrations. Experimental studies attribute the excess to a paracellular route through the tight junctions, which is driven by the osmotic water flow that SGLT1 creates. The regulation of these transporters, including their upregulation under high luminal sugar, is an active research area, and the absorption capacity of SGLT1 is one reason sodium-glucose transport is a clinical drug target.

Lipids, Micelles and the Lymphatic Route

Dietary triglycerides are broken down by pancreatic lipase into fatty acids and monoglycerides, and these products are solubilized by bile salts and phospholipids into micelles. When the micelle contacts the brush border, fatty acids and monoglycerides diffuse into the enterocyte, and a cytosolic fatty-acid-binding protein helps them move through the cell. Inside the enterocyte, they are re-esterified into triglycerides and packaged with apolipoproteins into chylomicrons. Because these particles are too large to enter the capillaries readily, they pass into lacteals, which are lymphatic capillaries located in the central core of each villus. The lymph carries them through the lymphatic system to the thoracic duct, which empties into the venous circulation near the left subclavian vein. Fatty acids of short and medium chain length are an exception: they can enter the portal blood directly and travel to the liver. Bile salts are not absorbed with the fats; they are reabsorbed in the terminal ileum and returned to the liver, a process described in the liver and biliary section.

Water-Soluble Nutrients and the Portal Route

Amino acids, dipeptides, tripeptides and monosaccharides leave the enterocyte and enter the capillary network of the villus, which drains into the hepatic portal vein. The liver therefore receives most of the absorbed water-soluble nutrients before they reach the rest of the body. Small peptides are taken up through the apical membrane by peptide transporters such as PepT1 and are broken down inside the cell, which adds to the free amino acid pool. Water itself moves mainly by osmosis, following the sodium and glucose that are absorbed. The small intestine absorbs the large majority of ingested water and electrolytes, and the colon completes the process of water retrieval.

Vitamins and Minerals

Fat-soluble vitamins (A, D, E and K) travel in micelles along with dietary lipids, so their absorption depends on adequate bile salt and pancreatic lipase activity. Most water-soluble vitamins, including the B vitamins other than B12 and vitamin C, enter by carrier-mediated or diffusion-based processes in the upper small intestine. Vitamin B12 is a special case: it binds intrinsic factor, a glycoprotein secreted by gastric parietal cells, and the complex is absorbed by receptor-mediated uptake in the terminal ileum. Calcium is absorbed by two routes. In the duodenum and upper jejunum, active transport depends on vitamin D and parathyroid hormone, and it is most effective when intake is low. In the lower small intestine, passive paracellular movement becomes more important as the luminal calcium load rises. Iron is absorbed mainly in the duodenum and upper jejunum. Heme iron is taken up intact, whereas non-heme iron is reduced to its ferrous form and enters the enterocyte through the divalent metal transporter DMT1. Once inside, iron is either stored in ferritin or exported across the basolateral membrane by ferroportin, whose activity is suppressed by the hormone hepcidin. Because the body has no active route for iron excretion, this regulated absorption is the main control of iron balance, and disturbances in it contribute to anemia.

Electrolyte transport is largely active. Sodium enters the cell along its electrochemical gradient and is pumped out into the interstitial fluid by the basolateral Na⁺/K⁺-ATPase. Chloride tends to follow sodium, and potassium moves partly by facilitated diffusion through ion channels. Water then follows the resulting osmotic gradient, linking electrolyte transport directly to the volume of fluid that leaves the lumen.

Gut Microbiota

The gastrointestinal tract is home to a large and varied community of microorganisms, mostly bacteria, along with archaea, fungi and viruses. Counts for the whole tract run above 100 trillion. Their composition is not uniform. The microbial composition of the gut microbiota varies across regions of the digestive tract. The colon is the most densely colonized segment. Estimates for bacterial cells in the colon reach 10^11 to 10^12 per milliliter, which makes it one of the most densely populated microbial habitats known. Its low oxygen, slow transit and supply of fermentable material favor this density. The colon contains the highest microbial density of any human-associated microbial community studied so far, representing between 300 and 1000 different species.

At the phylum level, a few groups dominate. Older reviews often describe Firmicutes and Bacteroidetes as representing 90% of gut microbiota, while current taxonomy lists the four dominant bacterial phyla in the human gut as Bacillota (Firmicutes), Bacteroidota, Actinomycetota, and Pseudomonadota. The estimates differ partly because of naming and methods. Within these phyla, a limited set of genera does most of the work. The Firmicutes phylum contains relevant genera, including Ruminococcus, Clostridium, Lactobacillus, and the butyrate producers Eubacterium, Faecalibacterium and Roseburia. In Bacteroidetes, Bacteroides, Prevotella and Xylanibacter degrade a variety of complex glycans. Bifidobacterium and Akkermansia are also common, and the latter is specialized for mucus degradation.

Much of the microbiota's metabolic role depends on fermentation. Human enzymes cannot break down many plant polysaccharides, so these compounds reach the colon largely intact. Due to their large repertoires of carbohydrate-active enzymes, bacteria in the gut are capable of degrading dietary undigested polysaccharides, such as resistant starch and dietary fiber, as well as host-produced mucus glycans, and producing short-chain fatty acids (SCFAs) and lactate as fermentation products. The main products are acetate, propionate and butyrate, which are found in the human intestine at concentrations of approximately 13 mM in the terminal ileum, ~130 mM in the caecum and ~80 mM in the descending colon. Butyrate is the most important for the host's own cells. In the cecum and large intestine, 95% of the produced SCFAs are rapidly absorbed by the colonocytes while the remaining 5% are secreted in the feces. Butyrate, in particular, is a preferred energy source for colonic epithelial cells. Estimates suggest that SCFAs provide 5 to 10% of human basal energy requirements. Germ-free mice, which lack these bacteria, show colonocytes with a deficit in mitochondrial respiration, and reduced colon cell proliferation, which is restored by the addition of butyrate ex vivo.

The microbiota also contributes vitamins the host cannot obtain in sufficient amounts from food. The gut microbiota produces essential vitamins, including B vitamins such as B12, folate and riboflavin, and vitamin K, which are important for various physiological functions. The dependence on microbes for vitamin K is shown by germ-free animals: GF rats fed a diet without vitamin K rapidly become haemorrhagic, which is why germ-free diets are fortified with these vitamins. Although the contribution of bacterial synthesis to host vitamin status varies with diet and host, it is a real source for some vitamins.

Another key function is colonization resistance, the ability of a resident community to keep pathogens out. This protective function involves direct and indirect competitive interactions between pathogens and commensal bacteria. Commensals compete for nutrients, produce inhibitory substances and stimulate host immune responses. Antibiotics disrupt bacterial community balance, enabling the invasion of pathogens such as Clostridioides difficile and Salmonella spp. While germ-free mice show minimal colonization resistance, this increases when microbial complexity increases. This is why antibiotic exposure is a recognized risk factor for enteric infection.

Several methods are used to study the microbiota. Germ-free and gnotobiotic animals are central. A gnotobiotic animal is colonized with a defined community, so investigators can test individual species or consortia; one example is a minimal community of 12 physiologically relevant bacteria. Sequencing of marker genes or whole metagenomes identifies which organisms are present, and metabolomics measures the small molecules they produce, such as SCFAs and bile-acid derivatives. Combining these approaches links taxonomy to function, but results depend on sampling, storage and analysis choices, which is why standardization remains an active concern.

Gut Immune Barrier

The intestinal wall must admit nutrients while keeping out the microorganisms and antigens that share the lumen. This is achieved through three overlapping layers: a physical epithelial barrier, a chemical mucus barrier, and an immune system embedded in the gut wall.

Epithelial and mucus barriers

The lining is a single layer of epithelial cells. The intestinal epithelium is composed of a continuous single layer of intestinal epithelial cells (IECs) that are sealed together by tight junctions (TJ) proteins. Tight junctions are built mainly from claudins, occludin and junctional adhesion molecules, which associate with peripheral intracellular membrane proteins, such as zonula occludens (ZO) proteins, which anchor them to the actin cytoskeleton. Adherens junctions and desmosomes supply mechanical strength, while tight junctions control how much material passes between cells. Tight junctions were once regarded as static seals, but recent studies indicate that they are much more dynamic than previously thought, and their permeability may be regulated by a number of factors that affect the epithelial cells.

Above the epithelium lies a mucus layer that is stratified. In mouse and human colon, the epithelial surface is protected by a thick network of mucus, which is composed of a dense, sterile inner layer and a loose outer layer that is colonized by commensal bacteria. The mucin Muc2 is needed to keep bacteria out of the inner layer. Mucin carbohydrates also bind microbes, which aids in preventing epithelial colonization and, by causing aggregation, accelerates clearance. Paneth cells add a further chemical layer by releasing antimicrobial peptides.

When these barriers weaken, the consequences are measurable. Dysregulation has been shown to increase intestinal permeability, inflammation, and translocation of pathogenic bacteria. The causal direction in many systemic conditions remains debated, a point discussed further in nutritional and metabolism research.

Gut-associated lymphoid tissue

The immune tissue of the gut is called gut-associated lymphoid tissue (GALT). The gut-associated lymphoid tissue (GALT) consists of isolated or aggregated lymphoid follicles forming Peyer's patches (PPs). Peyer's patches were first described by Johann Conrad Peyer in 1677, and are concentrated in the lower small intestine. Their density increases towards the terminal ileum, where they form a lymphoid ring at the ileocecal junction. Isolated lymphoid follicles are far more numerous and are distributed along the length of the small and large intestines. The appendix is another prominent site.

Peyer's patches are covered by a specialized follicle-associated epithelium containing microfold (M) cells. These cells sample antigen directly from the lumen and deliver it to antigen-presenting cells beneath the surface. Dendritic cells can also reach into the lumen, extending dendrites through transcellular M cell-specific pores. The follicles contain CD4+ T helper cells, mature B cells, macrophages, and dendritic cells.

Secretory IgA and tolerance

Secretory IgA (SIgA) is the dominant antibody of the gut. It is transported across intestinal epithelial cells into gut secretions by the polymeric immunoglobulin receptor (pIgR). Microbial signals help set this up. Dendritic cells stimulated by microbes produce signals that enhance IgA isotype switching in B-cells, promoting IgA production within Peyer's patches. Germ-free animals make little IgA, and production is restored soon after the colonization of commensal bacteria, which shows that commensals help build the mucosal immune system.

Two pathways produce gut IgA. The T cell-dependent route targets bacteria that penetrate the barrier, and its induction requires engagement of CD40 on B cells by CD40 ligand on T follicular helper cells. The T cell-independent route generates antibodies that specifically recognize commensal bacteria with polyreactive binding modalities. Commensal-derived signals also push dendritic cells toward a tolerant state. For example, commensal bacteria-derived butyrate stimulates iECs to produce RA, thereby inducing tolerogenic DCs.

Tolerance is central because the mucosal system must avoid harming its own tissues. The mucosal immune system must maintain a finely tuned balance between tolerance and responsiveness to mucosal antigens, including TI-antigens derived from the microbiota. When this balance fails, erroneous activation of the mucosal immune system can result in chronic inflammation and development of autoimmunity or allergy.

Innate and adaptive interplay

Innate and adaptive responses operate together. Epithelial cells, mucus and Paneth cell peptides form the first line, while innate sensors on dendritic cells and epithelial cells detect microbial components. Adaptive IgA then extends that defense. Coating of pathogens can mediate bacterial agglutination, which retains pathogenic bacteria in the gut lumen and prevents bacterial interactions with the mucosal tissue—a process referred to as immune exclusion. The same antibodies also shape the resident community, and SIgA shapes the composition of the gut microbiome.

Continuous microbial exposure is itself part of normal function. In the intestine, the continuous stimulation by commensal bacteria may induce "homeostatic inflammation," which is essential for IgA production. The same principle has a downside: in one colitis model, commensal bacteria coated with high levels of IgA are more pathogenic than low IgA- and non-coated bacteria. The gut immune barrier therefore shapes both protection and inflammation, and the outcome depends on the balance between microbes, epithelium and immune cells. Whether a given individual's antibody repertoire is tuned to his or her own microbiota is a further question, and early work suggests the IgA antibody repertoire is shaped uniquely to bind "self" gut bacteria.

Development and Comparative Anatomy

The digestive tract starts as a simple tube. In human embryos, the primitive gut tube forms in the third week, and by the fourth week three regions can be told apart: the foregut, midgut and hindgut. Each region has its own arterial supply, from the celiac, superior mesenteric and inferior mesenteric arteries, and these vascular territories remain a practical way to trace which adult structures come from which segment. The foregut gives rise to the pharynx, esophagus, stomach and upper duodenum, and the liver and pancreas bud from it. The midgut forms most of the small intestine and the proximal colon, and the hindgut forms the distal colon, rectum and upper anal canal. In the midgut, a loop herniates through the umbilicus during the sixth week, elongates, returns to the abdomen and rotates. This rotation fixes the large intestine in its adult position within the peritoneal cavity.

The enteric nervous system has a different origin. It is built from neural crest cells, a migratory population from the neural tube. Most of these cells come from the vagal region of the caudal hindbrain. They enter the foregut and migrate caudally along the gut, reaching the whole length of the tract by about the seventh week in human development. A second, sacral population enters the hindgut and contributes neurons and glia to the segment below the umbilicus. The interstitial cells of Cajal, which generate the electrical rhythm of intestinal smooth muscle, are an exception: they arise from mesoderm rather than from neural crest. When neural crest migration is incomplete, distal segments lack enteric ganglia. This produces Hirschsprung disease, which affects roughly 1 in 5,000 live births and leaves the affected bowel without normal peristalsis. The distal bowel is most often involved because its colonizing cells must travel the farthest.

Vertebrate digestive systems share a common plan, but they differ widely in chamber number, intestinal length and the location of fermentation. Birds have no teeth and rely on a two-part stomach. The first part, the proventriculus, is glandular and secretes acid and enzymes. The second, the muscular gizzard, grinds food with swallowed grit, or gastroliths, that accumulate in it. The small intestine of birds is broadly similar to that of mammals, but the large intestine is short, and two blind ceca sit at the junction of the small and large intestine.

Ruminants such as cattle, sheep, goats and deer have a stomach divided into four compartments: the rumen, reticulum, omasum and abomasum. The rumen and reticulum together make up about 84 percent of the stomach's volume. Their microbial communities break down cellulose by fermentation and produce volatile fatty acids, which the animal absorbs. The omasum absorbs water and electrolytes, while the abomasum is glandular and works much like the simple stomach of a monogastric animal. The hippopotamus, which is not a ruminant, has a multichambered stomach that resembles the ruminant one in some respects. In young ruminants, the proportions of the four compartments shift as the animal matures and begins to eat forage, and the abomasum becomes proportionally smaller.

Herbivores that do not use a forestomach, such as horses and rabbits, rely instead on hindgut fermentation, with a large cecum and colon housing the microbes that digest fiber. Carnivores typically have a relatively short intestine for their body size and a simpler stomach, consistent with a diet of readily digested animal tissue. These are broad patterns rather than rules, and many species combine features in different ways.

Across mammals, intestinal length and specialization tend to track diet and body size. Plant-eating species generally have longer intestines relative to body length than meat-eating ones. Features such as an enlarged cecum, chambered stomachs and changes in the relative size of the small and large intestine have appeared repeatedly in different evolutionary lineages. Because these features arise from different developmental routes, comparative anatomy offers a way to link developmental change to dietary adaptation.

History of Study

For roughly two thousand years, explanations of digestion were largely theoretical. In ancient Greek and Roman medicine, physicians such as Hippocrates and Galen linked digestion and health to the balance of bodily fluids, or humours. This humoral framework shaped thinking about food, the stomach and the body's "concoction" of nutrients for centuries, and it gave way to chemical and experimental accounts only gradually, during the eighteenth and nineteenth centuries.

The first direct observations of human gastric digestion came from an accident. On June 6, 1822, on Mackinac Island, an employee of the American Fur Company named Alexis St. Martin was accidentally shot in the stomach at close range. The army surgeon William Beaumont treated him, and the musket shot left a wound that developed into a fistula connecting his stomach to the outside of his body. Beaumont used this opening to study digestion. He placed food on strings directly into the stomach and withdrew gastric secretions for observation. Beaumont's work was not a single experiment: he studied St. Martin from 1825 through 1833, and his preliminary reports appeared in The Medical Recorder in 1825 and 1826. His most important finding was that digestion was largely a chemical process rather than the churning and pulverisation that had been assumed. His observations were later published as a book, and an English edition appeared in 1838 with an editorial introduction by Andrew Combe. The same studies are also remembered for their ethical problems. St. Martin endured 17-hour fasts and constant poking and prodding, and his consent and welfare are still discussed by historians of medicine.

A second landmark came from the laboratory of Ivan Pavlov. The Nobel Prize was given in 1904 for his research on the neural control of salivary, gastric, and pancreatic secretion. He was the first physiologist to win the Nobel Prize. Pavlov's method was as important as his findings. A major reason for the success and novelty of his research was the use of unanesthetized dogs surgically prepared with chronic fistulas or gastric pouches that permitted repeated experiments in the same animal for months. This approach allowed him to study secretion in intact, awake animals. His earlier work had shown that the vagus nerve acts as a secretory nerve for the pancreas (1888) and the gastric glands (1889). Pavlov also described psychic secretions as conditional responses, showing that the sight or presence of food could change the flow of digestive juices. The Nobel Committee's recognition of his work also reflected the wider importance of the nervous system in regulating the gut. Later, a small number of other gastrointestinal physiologists were recognized: five laureates have received the prize in the area of gastrointestinal physiology up to 2016.

Discoveries in the late nineteenth and early twentieth centuries also identified the chemical messengers of the gut. In 1902, William Bayliss and Ernest Starling described secretin, a substance released from the duodenum that stimulates pancreatic secretion, which became the first hormone to be recognized as such. Gastrin, which stimulates acid production in the stomach, was characterized in the following years. These findings established the endocrine control of digestion that is discussed in the sections on hormones and on the pancreas.

Much of modern knowledge depends on tools that arrived in the twentieth and twenty-first centuries. Radiographic studies using barium meals and fluoroscopy made the movement of the intestine visible in living patients from the early 1900s. From the 1950s onward, flexible fibreoptic endoscopes allowed clinicians and researchers to inspect the stomach and bowel directly and to take tissue samples for biopsy. More recently, molecular techniques, including the analysis of gene expression and the sequencing of microbial DNA, have extended the study of digestion from the level of organs to that of cells and communities.

Disorders of the Digestive System

Disorders of the digestive system can be grouped by their main mechanism: acid- and infection-driven injury to the upper tract, immune-mediated damage to the intestinal wall, disturbed gut-brain signalling without visible structural lesions, and neoplasia. These categories overlap, and some conditions involve more than one.

Esophageal and gastric disorders

In gastroesophageal reflux disease (GERD), acidic stomach contents move back into the esophagus and cause heartburn, chest discomfort and inflammation of the mucosa. GERD may be related to several risk factors, including obesity, smoking, and pregnancy. Prolonged acid exposure can lead to peptic stricture, Barrett's esophagus, and esophageal cancer.

Peptic ulcer disease is most often linked to Helicobacter pylori, a bacterium that colonizes the gastric lining. It is a gram-negative bacillus that adheres mainly to the gastric mucosa, causing peptic ulcers and gastritis. The organism is also a recognized cause of gastric cancer. Eradication therapy heals inflamed mucosa and existing ulcers, reduces the chance of new ulcers, and lowers gastric cancer risk, and it also prevents transmission of the infection. However, H. pylori infection has become increasingly difficult to cure, in part due to the emergence of antimicrobial resistance.

The relationship between H. pylori and reflux is paradoxical. The prevalence of H. pylori is inversely related to gastroesophageal reflux disease (GERD) and its sequelae, yet neither H. pylori infection nor H. pylori eradication causes gastroesophageal reflux disease (GERD). Host genetics also contributes to ulcer risk. A genome-wide study of more than 450,000 UK Biobank participants identified several loci, and there are previously established roles in susceptibility to Helicobacter pylori infection, response to counteract infection-related damage, gastric acid secretion or gastrointestinal motility for these genes.

Immune-mediated disorders

Celiac disease is an autoimmune enteropathy. It is triggered in genetically predisposed individuals by the ingestion of gluten, a family of proteins found in wheat, barley, and rye. Nearly all patients carry the HLA-DQ2 variant, and most of the remainder carry HLA-DQ8 . The enzyme tissue transglutaminase 2 modifies gluten peptides so they bind more strongly to these HLA molecules, which in turn activates CD4+ T cells . Cytokines released in this response also activate cytotoxic intraepithelial lymphocytes that destroy enterocytes, producing the villous atrophy seen on biopsy . Patients typically produce IgA autoantibodies against tissue transglutaminase . Current management relies on a strict, lifelong gluten-free diet .

Crohn's disease and ulcerative colitis, collectively termed inflammatory bowel disease, are chronic relapsing inflammatory conditions. Crohn's disease can affect any segment of the tract in patchy, transmural lesions, whereas ulcerative colitis is continuous and confined to the colon and rectum, beginning in the rectum. Current understanding holds that these diseases arise when genetically susceptible hosts mount a dysregulated mucosal immune response to commensal microbes, with barrier defects and cytokines such as TNF-α playing central roles. This pathway explains why biologic agents targeting TNF-α and related signals are important treatments, alongside anti-inflammatory drugs. The precise trigger for each disease remains unresolved.

Functional disorders

Irritable bowel syndrome (IBS) is a functional disorder defined by symptoms rather than by a visible lesion. It is characterized by recurrent abdominal pain in the absence of detectable organic, systemic, or metabolic disease. Under the Rome IV criteria, recurrent abdominal pain for a minimum of one day per week in the past 3 months, with a combination of two or more criteria relating to changes in defecation, stool frequency or stool form is required. Symptoms must also have begun at least six months earlier. Subtypes are defined by predominant stool consistency: IBS with predominantly constipation (IBS-C), IBS with predominantly diarrhea (IBS-D), IBS with mixed episodes (IBS-M), and IBS with unknown subtype (IBS-U).

The mechanisms are multifactorial. The proposed mechanisms underlying IBS include abnormal intestinal motility, visceral hypersensitivity, altered brain-gut interactions, low-grade mucosal inflammation, immune dysregulation, genetic predisposition, and gut microbiota imbalance. Visceral hypersensitivity, meaning heightened pain perception from normal intestinal stimuli, may be detected in up to 60% of IBS patients. Because no reliable biological marker exists, diagnosis remains largely clinical.

Colorectal cancer

Colorectal cancer is one of the most common cancers and a major cause of cancer death. Most tumors develop through a sequence in which benign adenomatous polyps accumulate genetic changes, often beginning with loss of the APC tumor suppressor. Established risk factors include advancing age, family history and hereditary syndromes such as Lynch syndrome and familial adenomatous polyposis, long-standing colitis, obesity, low fiber intake, high consumption of red and processed meat, smoking, heavy alcohol use and physical inactivity.

The microbiota has drawn increasing attention as a contributor. Fusobacterium nucleatum has been repeatedly detected in colorectal tumors, and strains of Escherichia coli carrying the pks genotoype produce colibactin, a genotoxin that damages DNA. Associations between these organisms and tumor mutation patterns have been reported, particularly in early-onset disease, but whether they cause tumors or simply accompany them is still debated. Screening by colonoscopy and stool-based tests has reduced mortality in populations where it is widely used.

Diagnosis and Treatment

Diagnostic approaches

Evaluation usually starts with history, physical examination and laboratory tests, then moves to direct visualization of the tract. An upper gastrointestinal (GI) endoscopy examines the oesophagus, stomach and duodenum using a flexible telescope. It is used to investigate swallowing difficulties, nausea, vomiting, reflux, bleeding, indigestion, abdominal pain or chest pain. Colonoscopy uses a flexible endoscope passed through the anus to examine the entire colon, where it can obtain tissue samples, remove polyps, detect cancer and diagnose causes of bleeding or inflammation. Endoscopic ultrasound extends the view beyond the gut wall, so that the pancreas, liver, bile ducts, and gallbladder can be assessed for conditions such as pancreatitis and gallstones.

Biopsy is the main means of confirming a diagnosis made by endoscopy. Biopsies can test for conditions such as celiac disease, H. pylori infection, or cancer. Histological examination also detects villous atrophy in the small intestine in celiac disease. The appearance seen through the scope does not always match the microscopic picture. A retrospective study of 114 patients found strong agreement between endoscopic and histological diagnoses for oesophagitis and gastritis, but weaker agreement for duodenal lesions, and Cohen's kappa values indicated poor overall agreement across all sites. Diagnosis can also be delayed when mucosal changes are patchy: in one reported case of upper-tract Crohn's disease, video capsule endoscopy revealed duodenitis and aphthous ulcers, and subsequent esophagogastroduodenoscopy with histology confirmed focal inflammation.

Laboratory markers complement these procedures. Stool calprotectin, a protein released by inflammatory cells, is used as an indicator of intestinal inflammation; in the same case report, fecal calprotectin remained elevated despite repeated treatment changes. Blood tests detect anemia and nutritional deficiencies, and breath tests are used for certain bacterial and carbohydrate-malabsorption questions. Cross-sectional imaging, including CT, MRI and contrast radiography, shows structural abnormalities such as strictures, masses and fistulas.

Pharmacological treatment

Acid suppressants, chiefly proton pump inhibitors and H2 receptor antagonists, reduce gastric acid secretion and are the mainstay for reflux disease and peptic ulcers. Eradication of H. pylori combines antibiotics with acid suppression, and the emergence of resistant strains has made the choice of regimen increasingly dependent on local resistance patterns (see antibiotic resistance). Antibiotics are also used for specific infections and, in some cases, for bacterial overgrowth.

Inflammatory bowel disease is treated with anti-inflammatory agents such as aminosalicylates and corticosteroids, followed by immunomodulators and monoclonal antibody biologics that block cytokines such as tumour necrosis factor. These agents are directed at the immune system and carry risks of infection, which is why they are generally reserved for moderate to severe disease.

Probiotics occupy a more contested position. A consensus review of randomised trials concluded that specific probiotics can relieve lower GI symptoms in IBS, prevent diarrhoea associated with antibiotics and H. pylori eradication therapy, and show favourable safety. A separate systematic review found that probiotics had little or no effect for the maintenance of remission from ulcerative colitis and Crohn's disease. Because benefits cannot be generalised between different probiotics, guidance names individual strains for each indication, and the evidence base for probiotic use remains strain-specific and condition-specific.

Surgical procedures

Gastrectomy, the partial or total removal of the stomach, is performed for gastric cancer and for complicated ulcers, while colectomy removes all or part of the colon for colorectal cancer, refractory colitis or complications of diverticular disease. Endoscopic methods are increasingly used for early lesions, reducing the need for resection.

Bariatric surgery is the most heavily regulated surgical indication. The 1991 NIH criteria, which have been used by providers, hospitals, and insurers, as a standard for selection criteria for bariatric surgery. A body mass index (BMI) >40 kg/m2, or BMI >35 kg/m2 with co-morbidities, is a threshold for surgery that is applied universally. The 2022 ASMBS and IFSO guideline lowered this threshold: metabolic and bariatric surgery is recommended for individuals with a BMI ≥35 kg/m2, regardless of presence, absence, or severity of co-morbidities, and should be considered for individuals with metabolic disease and BMI of 30-34.9 kg/m2. Currently, the dominant procedures are sleeve gastrectomy and RYGB, together accounting for approximately 90% of all operations performed worldwide. Candidates are expected to undergo evaluation by a multidisciplinary team and to remain under long-term medical follow-up. Endoscopic devices that modify gastric anatomy have also been approved for patients in defined BMI ranges, although their use is limited by reimbursement and access barriers in some settings.

Nutritional management

Dietary modification is a first-line measure for several conditions. Elimination diets are used in functional bowel disorders and food intolerance, and strict gluten avoidance is the only established treatment for celiac disease. In the Crohn's case noted above, the patient's symptoms persisted, necessitating comprehensive nutritional management, which is a common situation in severe disease. When oral intake is insufficient or the intestine cannot absorb adequately, enteral nutrition delivers a formula through a tube into a functioning gut, while parenteral nutrition supplies nutrients intravenously and bypasses the digestive tract altogether.

Open Questions and Research Frontiers

Gut microbiota and neurological or psychiatric conditions

Associations between the gut microbiota and conditions such as Parkinson's disease and depression have been reported in many studies, but the direction of cause and effect is still unresolved. Metagenome-wide association studies have linked microbial profiles to Parkinson's risk, yet whether the microbes help drive the disease or simply change along with it has not been established. Some observations suggest the shifts are not merely downstream of the illness. Reduced microbial diversity, a drop in Firmicutes and a rise in Proteobacteria recur across reviews, and similar changes have appeared in early-stage patients who had not yet taken medication. Altered tryptophan metabolism is another candidate mechanism, but it is still unclear whether it causes the disease or results from it.

Mendelian randomization, which uses inherited genetic variants as instrumental variables, is one way to probe causality while reducing confounding and reverse causation. It cannot replace randomized controlled trials, which remain the gold standard but are costly and logistically difficult to run for long-term neuropsychiatric outcomes. Human intervention data are therefore still limited, and most mechanistic evidence comes from animal models.

Relative contributions of neural, immune and microbial factors

Irritable bowel syndrome and inflammatory bowel disease probably arise from several interacting systems at once, including the neuronal networks of the enteric nervous system, the mucosal immune system and the resident bacteria. No single component has yet been shown to dominate in either condition. Visceral hypersensitivity and altered motility are central to irritable bowel syndrome, but it is not known whether these abnormalities start in the nerves, the immune environment or the microbial community. In inflammatory bowel disease, immune-driven inflammation is well documented, while the microbial triggers and the role of neural signalling remain under study. A persistent difficulty is that symptoms, diet, medication and inflammation tend to change together, which makes it hard to separate primary drivers from consequences.

Gut–brain communication and therapeutic targeting

Signals between the gut and the brain appear to travel along vagal afferent fibres, through the circulation and through neuroendocrine and immune routes. Microbial metabolites such as short-chain fatty acids and bile acids have been proposed to act on receptors on vagal nerve terminals, and specialized enteroendocrine cells have been described as forming synapses with vagal and enteric neurons in experimental systems. How these routes operate in humans, and which of them matter most for disease, remains an open question.

Therapeutic interest is growing. Vagus nerve stimulation is a recognized option for treatment-resistant depression in some psychiatric guidelines, though the implanted form requires surgery, and noninvasive approaches are under investigation. Probiotics, prebiotics and fecal microbiota transplantation have produced encouraging but variable results in neurological and psychiatric studies. Key uncertainties include whether the effects of stimulation depend on microbial composition, how to target a specific pathway without affecting others, and how to choose patients likely to benefit. Answering these questions will depend on careful mental health outcome measures alongside gut-based markers.

Standardization of microbiome measurements and trial design

A major obstacle is the lack of common methods. A recent multidisciplinary Delphi consensus, built from two survey rounds involving dozens of experts, concluded that clinical microbiome studies still lack a minimum metadata set, agreed reference materials, standardized sampling and analysis procedures, and unified clinical end points. Reporting frameworks such as the STORMS checklist, which draws on the STROBE and STREGA guidelines, aim to make methods transparent, although some commentators argue that transparent reporting and justification of methods should take priority over rigid standardization.

These gaps affect clinical use as well as research. An international consensus on microbiome testing noted that evidence for the clinical usefulness of gut microbiome tests is scarce, while commercial direct-to-consumer tests continue to expand. Trial design presents its own problems, because probiotics, prebiotics, postbiotics, phages, dietary interventions and fecal transplantation each require different controls, dosing definitions and outcome measures before results can be compared across studies.

References

1. Accessory Pancreatic Duct - an overviewsciencedirect.com
2. Ampulla of Vater - an overviewsciencedirect.com
3. 22.10A: Anatomy of the Small Intestine - Medicine LibreTextsmed.libretexts.org
4. Small Intestine Anatomy: Overview, Gross Anatomy, Microscopic Anatomyemedicine.medscape.com
5. Surface area of the digestive tract - revisited - PubMedpubmed.ncbi.nlm.nih.gov
6. How long are your intestines? Length of small and large intestinemedicalnewstoday.com
7. Small intestineen.wikipedia.org
8. The Small and Large Intestinescourses.lumenlearning.com
9. Small intestinebritannica.com
10. Digestion and Absorptionbooks.lib.uoguelph.ca
11. Intestinal secretory mechanisms and diarrhea - PMC - NIHpmc.ncbi.nlm.nih.gov
12. Chapter 5. Water and Electrolyte Absorption and Secretionaccessmedicine.mhmedical.com
13. Intestinal Fluid Handling: Absorptionlink.springer.com
14. Absorption of Water and Electrolytes in the Intestinevivo.colostate.edu
15. Medical Physiology/Gastrointestinal Physiology/Secretions - Wikibooks, open books for an open worlden.wikibooks.org
16. Composition, volumes and regulation of gastrointestinal secretionsderangedphysiology.com
17. Hormonal and neural regulation of digestive processesiu.pressbooks.pub
18. Mechanisms controlling hormone secretion in human gut and its relevance to metabolismncbi.nlm.nih.gov
19. The Impact of Environmental Factors on the Secretion of Gastrointestinal Hormonesncbi.nlm.nih.gov
20. Neural control of gut homeostasisjournals.physiology.org
21. Submucosaen.wikipedia.org
22. Gastrointestinal wallen.wikipedia.org
23. 12.3: Structural Organization of the Intestinal Wall and Peritoneum - Medicine LibreTextsmed.libretexts.org
24. Overview of the Digestive Systemcourses.lumenlearning.com
25. Dialkyl-phosphinoyl-alkane (Dapa) compounds and compositions for treatment of lower gastrointestinal tract disordersimage-ppubs.uspto.gov
26. 5. Digestive System: Tissue Layers of the Gastrointestinal Tract - LabXchangelabxchange.org
27. 14.3 Anatomy of the Gastrointestinal Systemwtcs.pressbooks.pub
28. Layers of the Gastrointestinal Tractgeekymedics.com
29. Stomach histology: Mucosa, glands and layerskenhub.com
30. Peritoneum: Anatomy, Function, Location & Definitionmy.clevelandclinic.org
31. Peritoneumen.wikipedia.org
32. The Mesentery - Function - Structure - Vasculature - TeachMeAnatomyteachmeanatomy.info
33. Chapter 26: The abdominal viscera and peritoneumhumananatomy.host.dartmouth.edu
34. Peritoneum Anatomy: From Basics to Clinical Applicationjove.com
35. Celiac trunk: Anatomy, branches and functionkenhub.com
36. Celiac Artery - an overviewsciencedirect.com
37. Celiac and Mesenteric Arteriesbasicmedicalkey.com
38. Anatomy, Abdomen and Pelvis, Portal Venous System (Hepatic Portal System) - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
39. Blood vessels of abdomen and pelvis : Anatomy overviewkenhub.com
40. Mesentery vs. Peritoneumstudy.com
41. Peritoneum and peritoneal cavity: Anatomy and functionkenhub.com
42. Physiology of oral, pharyngeal, and esophageal motility : GI Motility onlinenature.com
43. Secretion of Saliva - Modifications - Clinical Relevanceteachmephysiology.com
44. Lingual Lipase - an overviewsciencedirect.com
45. Secretions of Human Salivary Glandintechopen.com
46. Physiology of swallowing - ScienceDirectsciencedirect.com
47. Surgical anatomy and physiology of swallowing - ScienceDirectsciencedirect.com
48. Deglutition - an overviewsciencedirect.com
49. Swallowing - Phases - Control - TeachMePhysiologyteachmephysiology.com
50. Physiology, Lower Esophageal Sphincterstatpearls.com
51. Upper esophageal sphincter : GI Motility onlinenature.com
52. The esophageal sphincter: What to knowmedicalnewstoday.com
53. Esophageal peristalsis : GI Motility onlinenature.com
54. Anatomy, Abdomen and Pelvis, Small Intestine - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
55. Anatomy of the small intestine - ScienceDirectsciencedirect.com
56. The Anatomy and Functions of the Small Intestine in the Digestive Systemsiloamhospitals.com
57. Ileumbritannica.com
58. GI Absorption PDFpicmonic.com
59. Ileum Resection - an overviewsciencedirect.com
60. Bile salt diarrhoea Patient information University Hospitals Sussexuhsussex.nhs.uk
61. Gastrointestinal tract 4: anatomy and role of the jejunum and ileumnursingtimes.net
62. Brush Border - an overviewsciencedirect.com
63. Physiology, Small Bowel - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
64. Microvillusbritannica.com
65. Ileumen.wikipedia.org
66. Bile Formation and Secretion - PMCpmc.ncbi.nlm.nih.gov
67. Bile Composition - an overviewsciencedirect.com
68. Bile secretion and enterohepatic circulation Videoosmosis.org
69. Bile Production - Constituents - TeachMePhysiologyteachmephysiology.com
70. Bile Salts - The Definitive Guidebiologydictionary.net
71. Methods for treating cholestasisimage-ppubs.uspto.gov
72. Cholecystokininpancreapedia.org
73. Role of nutrient fat and cholecystokinin in regulation of gallbladder emptying in manlink.springer.com
74. New Avenues in the Regulation of Gallbladder Motility—Implications for the Use of Glucagon-Like Peptide–Derived Drugsacademic.oup.com
75. Bile Acid Metabolism - an overviewsciencedirect.com
76. The Mechanism of Enterohepatic Circulation in the Formation of Gallstone Diseasencbi.nlm.nih.gov
77. Enterohepatic Circulation - an overviewsciencedirect.com
78. Enterohepatic circulationen.wikipedia.org
79. Benzothiadiazepine compounds and their use as bile acid modulatorsimage-ppubs.uspto.gov
80. Bile Acid Physiology and Alterations in the Enterohepatic Circulationabdominalkey.com
81. Acinar cellen.wikipedia.org
82. Histology Of Digestive Organs Labmedcell.org
83. Anatomy and Physiology of the Pancreas ‣ Pancreas Academyepc-pancreasacademy.com
84. Protein Composition and Biogenesis of the Pancreatic Zymogen Granulespancreapedia.org
85. Methods and compositions for the treatment of pancreatitisimage-ppubs.uspto.gov
86. Activation of Soluble Adenylyl Cyclase Protects against Secretagogue Stimulated Zymogen Activation in Rat Pancreaic Acinar Cellsncbi.nlm.nih.gov
87. Pancreatic isletsen.wikipedia.org
88. Systems and methods for modulation of pancreatic endocrine secretion and treatment of diabetesimage-ppubs.uspto.gov
89. The Beta Cell in Its Cluster: Stochastic Graphs of Beta Cell Connectivity in the Islets of Langerhansncbi.nlm.nih.gov
90. Illuminating the complete ß-cell mass of the human pancreas- signifying a new view on the islets of Langerhansnature.com
91. Pancreas++: Automated Quantification of Pancreatic Islet Cells in Microscopy Imagesncbi.nlm.nih.gov
92. The Endocrine Pancreascourses.lumenlearning.com
93. Gastrointestinal tract 5: the anatomy and functions of the large intestinenursingtimes.net
94. 🧬 Large Intestine Anatomy: Structure and Function of the Colon — King of the Curvekingofthecurve.org
95. Large Intestine - an overviewsciencedirect.com
96. Absorption in the Large Intestine - Regulation - TeachMePhysiologyteachmephysiology.com
97. Physiology, Defecation - StatPearls - NCBI Bookshelf - NIHncbi.nlm.nih.gov
98. Defecationiu.pressbooks.pub
99. The physiology of continence and evacuation - ScienceDirectsciencedirect.com
100. Anatomy & Physiology Study Guide: Large Intestine, Liverpearson.com
101. Anismusen.wikipedia.org
102. Internal anal sphincteren.wikipedia.org
103. MacFarlane, N. G. (2018) Gut motility and its control. Anaesthesia andeprints.gla.ac.uk
104. Migrating Myoelectric Complex - an overviewsciencedirect.com
105. Introductory Human Physiology ©copyright Emma Jakoi 1 DIGESTIVE SYSTEM - 4histology.oit.duke.edu
106. Gastrointestinal Motilityuen.pressbooks.pub
107. Migrating motor complexen.wikipedia.org
108. Migrating Motor Complex - an overviewsciencedirect.com
109. Gastrointestinal physiologyen.wikipedia.org
110. Sphincters of the Digestive System: Guardians of Digestive Flow - Birmingham Gastroenterology Associatesbgapc.com
111. The Small and Large Intestinescourses.lumenlearning.com
112. <R/HEADS>PHYSIOLOGY Gut motility and its control Shona McQuilkeneprints.gla.ac.uk
113. How Long Does Food Actually Take to Go Through Your Body? A Step-by-Step Digestive Timelinehealthspectra.com
114. Intestine Transit Time - an overviewsciencedirect.com
115. Normal Transit Time for Food and Digestion Duration Explainedbodyspec.com
116. Advancing human gut microbiota research by considering gut transit time - PMCpmc.ncbi.nlm.nih.gov
117. Associations Between Physical Activity and Gastrointestinal Transit Times in People with Normal Weight, Overweight, and Obesity - ScienceDirectsciencedirect.com
118. Associations Between Physical Activity and Gastrointestinal Transit Times in People with Normal Weight, Overweight, and Obesity - The Journal of Nutritionjn.nutrition.org
119. The enteric nervous systemjournals.physiology.org
120. The Enteric Nervous System and Its Emerging Role as a Therapeutic Target - PMCpmc.ncbi.nlm.nih.gov
121. Functional circuits and signal processing in the enteric nervous systemlink.springer.com
122. 22.2A: Enteric Nervous System - Medicine LibreTextsmed.libretexts.org
123. Phases of Gastric Secretions in the Stomachourcancerstories.com
124. Explain how the gastric secretion of - HCl - Vaiavaia.com
125. Describe the regulation of the cephalic, gastric, and intestinal - Marieb, Hoehn 7th Edition Ch 22 Problem 23pearson.com
126. 34.4: Digestive System Regulation - Biology LibreTextsbio.libretexts.org
127. The Impact of Environmental Factors on the Secretion of Gastrointestinal Hormones - PMCpmc.ncbi.nlm.nih.gov
128. Gastrointestinal Tract Hormone - an overviewsciencedirect.com
129. Methods of purifying zsig33image-ppubs.uspto.gov
130. Gastrointestinal Hormone - an overviewsciencedirect.com
131. Functional, Diagnostic and Therapeutic Aspects of Gastrointestinal Hormonesgastrores.org
132. Cephalic Phase - an overviewsciencedirect.com
133. Enteric Nervous System - an overviewsciencedirect.com
134. Cephalic Phase in Anorexia Nervosa,Bulimia Nervosa and Obese Binge Eatersclinicaltrials.gov
135. How does each of the three phases of gastric secretion promote - Martini, Nath, Bartholomew 11th Edition Ch 24 Problem 27pearson.com
136. Hormones Involved in Gastrointestinal Processesstudy.com
137. Gastrointestinal Hormonesstudy.com
138. Carbohydrate digestion and absorption - Free USMLE Reviewgetoncourse.ai
139. Sucrase Isomaltase - an overviewsciencedirect.com
140. Pepsin A - an overviewsciencedirect.com
141. Chymotrypsin Trypsin - an overviewsciencedirect.com
142. Intestine Brush Border - an overviewsciencedirect.com
143. Enteropeptidase - an overviewsciencedirect.com
144. Colipase - an overviewsciencedirect.com
145. Biochemistry: Lipid Digestion and Absorption - Jack Westinjackwestin.com
146. 3.44 Lipid Digestion in the Small Intestinecourses.lumenlearning.com
147. [The pancreatic lipase/colipase system] - PubMedpubmed.ncbi.nlm.nih.gov
148. 15.3 Digestive System Processesopentextbc.ca
149. Acylglycerol Lipases (Neutral Lipid Hydrolysis)aocs.org
150. Regulation of Intestinal Glucose Absorption by Ion Channels and Transportersncbi.nlm.nih.gov
151. Glucose transporters in the small intestine in health and diseasencbi.nlm.nih.gov
152. The Role of SGLT1 and GLUT2 in Intestinal Glucose Transport and Sensingncbi.nlm.nih.gov
153. Glucose absorption by isolated, vascularly perfused rat intestine: A significant paracellular contribution augmented by SGLT1 inhibition - PMCpmc.ncbi.nlm.nih.gov
154. Computational Modelling of Glucose Uptake by SGLT1 and Apical GLUT2 in the Enterocytencbi.nlm.nih.gov
155. Sodium Glucose Cotransporter 1 - an overviewsciencedirect.com
156. Small Intestine Absorption PDFpicmonic.com
157. Small Intestine Absorption - Digestion & Absorption - Physiology - Picmonic for Medicinepicmonic.com
158. Small Intestine Absorptionstudy.com
159. Chemical Digestion and Absorption: A Closer Lookcourses.lumenlearning.com
160. Small Intestine Absorption - an overviewsciencedirect.com
161. Absorptionapp.achievable.me
162. Absorption: Locations and Processes - Free Sketchy MCAT Lessonsketchy.com
163. Mineral, Vitamin and Water Absorption in Anatomy and ...jove.com
164. High-absorption mineral-containing composition and foodsimage-ppubs.uspto.gov
165. Iron Absorption: Factors, Limitations, and Improvement Methodspubs.acs.org
166. Absorption of Nutrientsnutrientsreview.com
167. Gut microbiotaen.wikipedia.org
168. What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases - PMCpmc.ncbi.nlm.nih.gov
169. Devices, systems and methods for the production of humanized gut commensal microbiotaimage-ppubs.uspto.gov
170. Genomic reconstruction of short-chain fatty acid production by the human gut microbiotancbi.nlm.nih.gov
171. Regulation of Inflammation by Short Chain Fatty Acidsncbi.nlm.nih.gov
172. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism - PMCpmc.ncbi.nlm.nih.gov
173. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Diseasencbi.nlm.nih.gov
174. A guide to germ‐free and gnotobiotic mouse technology to study health and disease - Jans - 2025 - The FEBS Journal - Wiley Online Libraryfebs.onlinelibrary.wiley.com
175. Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavioracademic.oup.com
176. Anaerobic Bacteria in the Gut Microbiota Confer Colonization Resistance Against ESBL-Producing *Escherichia coli* in Micebiorxiv.org
177. P51 Enrichment of drug resistant Klebsiella pneumoniae in the gut following antibiotics alters the colonic immune landscapencbi.nlm.nih.gov
178. Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation - ScienceDirectsciencedirect.com
179. Baseline human gut microbiota profile in healthy people and standard reporting templatejournals.plos.org
180. Composition of the gut microbiota. The most represented phyla are...researchgate.net
181. Epithelial barrier function in gut-bone signaling - PMC - NIHpmc.ncbi.nlm.nih.gov
182. Mucins and isoforms thereof in diseases characterized by barrier dysfunctionimage-ppubs.uspto.gov
183. The Gastrointestinal Barriervivo.colostate.edu
184. Secretory IgA is Concentrated in the Outer Layer of Colonic Mucus along with Gut Bacteriancbi.nlm.nih.gov
185. Peyer′s Patches: The Immune Sensors of the Intestine - Jung - 2010 - International Journal of Inflammation - Wiley Online Libraryonlinelibrary.wiley.com
186. Human gut-associated lymphoid tissues (GALT); diversity, structure, and functionnature.com
187. Peyer's patchen.wikipedia.org
188. Gut-Associated Lymphoid Tissue - an overviewsciencedirect.com
189. Frontiersfrontiersin.org
190. Gut T cell-independent IgA responses to commensal bacteria require engagement of the TACI receptor on B cells - PMCpmc.ncbi.nlm.nih.gov
191. IgA B Cell Responses to Gut Mucosal Antigens: Do We Know it all?ncbi.nlm.nih.gov
192. Microbiota-antibody interactions that regulate gut homeostasis - ScienceDirectsciencedirect.com
193. Immunoglobulin A antibody composition is sculpted to bind the self gut microbiomescience.org
194. Intestinal Mucosal Barrier - an overviewsciencedirect.com
195. MUC13 negatively regulates tight junction proteins and intestinal epithelial barrier integrity via protein kinase Cjournals.biologists.com
196. Large intestine embryogenesis: Molecular pathways and related disorders (Review) - PMCpmc.ncbi.nlm.nih.gov
197. Gastrointestinal Tract Development - Embryologyembryology.med.unsw.edu.au
198. Gastrointestinal Tract - Intestine Development - Embryologyembryology.med.unsw.edu.au
199. Gastrointestinal tract - Knowledge @ AMBOSSamboss.com
200. Single-cell profiling coupled with lineage analysis reveals distinct sacral neural crest contributions to the developing enteric nervous systembiorxiv.org
201. Single-cell profiling coupled with lineage analysis reveals vagal and sacral neural crest contributions to the developing enteric nervous systemncbi.nlm.nih.gov
202. Essential Role of BMP4 Signaling in the Avian Ceca in Colorectal Enteric Nervous System Developmentncbi.nlm.nih.gov
203. Ruminant Stomach - an overviewsciencedirect.com
204. Understanding the Ruminant Animal Digestive Systemextension.msstate.edu
205. Digestive System of Goats - Cornell CALScals.cornell.edu
206. Gizzard - an overviewsciencedirect.com
207. Why Do Birds Eat Stones? (Complete Guide)birdfact.com
208. Recombinant bacterial phytases and uses thereofimage-ppubs.uspto.gov
209. William Beaumonten.wikipedia.org
210. Alexis St. Martinen.wikipedia.org
211. The man with the hole in his side - The Lancetthelancet.com
212. The Father of Gastric Physiology Bornconnecticuthistory.org
213. Beaumont of the Beaumont gastric fistula - Gastroenterologygastrojournal.org
214. Probing the Mysteries of Human Digestionsciencehistory.org
215. Pavlov and integrative physiology - PubMed - NIHpubmed.ncbi.nlm.nih.gov
216. Pavlov and integrative physiologyjournals.physiology.org
217. historical book of the week the work of the digestive glands 1902medicine.iu.edu
218. History of Development of Gastrointestinal Physiology: From Antiquity to Modern Period and the Birth of Modern Digestive Physiologylink.springer.com
219. William Beaumont’s momentous and unethical experimentsbecker.wustl.edu
220. Identifying the Demographic, Clinical, and Endoscopic Findings of Gastroesophageal Reflux Disease in Patients With Helicobacter pylori Infection at King Abdulaziz University Hospital, Jeddah, Saudi Arabiancbi.nlm.nih.gov
221. Current understandings of Helicobacter pylori, peptic ulcer and gastroesophageal reflux disease - PubMedpubmed.ncbi.nlm.nih.gov
222. Helicobacter pylori and Gastroesophageal Reflux Disease - PubMedpubmed.ncbi.nlm.nih.gov
223. GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depressionncbi.nlm.nih.gov
224. A dendritic cell population responsible for transglutaminase 2–mediated gluten antigen presentation in celiac diseasencbi.nlm.nih.gov
225. Immune cell dynamics and mechanisms of epithelial injury in celiac diseasencbi.nlm.nih.gov
226. Pathomechanisms in celiac disease - PubMedpubmed.ncbi.nlm.nih.gov
227. A dendritic cell population responsible for transglutaminase 2-mediated gluten antigen presentation in celiac diseasebiorxiv.org
228. [Irritable Bowel Syndrome] - PubMedpubmed.ncbi.nlm.nih.gov
229. Pathophysiological Mechanisms and Nonpharmacological Interventions in Irritable Bowel Syndrome: Current Insights and Future Directions - PMCpmc.ncbi.nlm.nih.gov
230. Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndromecdn.clinicaltrials.gov
231. Identifying the Demographic, Clinical, and Endoscopic Findings of Gastroesophageal Reflux Disease in Patients With Helicobacter pylori Infection at King Abdulaziz University Hospital, Jeddah, Saudi Arabia - PMCpmc.ncbi.nlm.nih.gov
232. New Rome IV Diagnostic Criteria for IBSirritablebowelsyndrome.net
233. Upper GI endoscopy and colonoscopyhealthdirect.gov.au
234. GI Endoscopy, Colonoscopy, Biopsyfroedtert.com
235. 7 Diseases That Can Be Detected by Upper Endoscopyresources.healthgrades.com
236. How Does An Upper Endoscopy Help Diagnose? - Austin Gastroenterologyaustingastro.com
237. Diseases Detected by Endoscopy: A Comprehensive Guidegastro1.com
238. Correlation of Endoscopic and Histopathological Diagnoses in Upper Gastrointestinal Tract Lesions: A Cross-Sectional Studyncbi.nlm.nih.gov
239. Diagnostic Challenges of Upper Gastrointestinal Tract Crohn’s Diseasencbi.nlm.nih.gov
240. (PDF) Systematic review: Probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensusresearchgate.net
241. Effects of Probiotics in Adults with Gastroenteritis: A Systematic Review and Meta-Analysis of Clinical Trialsncbi.nlm.nih.gov
242. Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guidencbi.nlm.nih.gov
243. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgeryncbi.nlm.nih.gov
244. 2022 American Society for Metabolic and Bariatric Surgery ...asmbs.org
245. Periprocedural Care for Patients Undergoing Bariatric Device Placement and Endoscopic Procedures - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
246. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery - ScienceDirectsciencedirect.com
247. Gut microbiota and Parkinson’s disease: exploring pathogenesis and potential therapeutic strategies from a gut-brain axis perspective - ScienceDirectsciencedirect.com
248. Gut Microbiome and Its Role in Parkinson's Diseasencbi.nlm.nih.gov
249. Interactions between gut microbiota and parkinson’s disease: the role of tryptophan metabolismlink.springer.com
250. Effects of gut microbiota on cognitive impairment in Parkinson’s disease: a comprehensive Mendelian randomization and case–control studyncbi.nlm.nih.gov
251. Multidisciplinary Delphi consensus statement on minimal standards for clinical metadata and end points in microbiome studiesnature.com
252. STREAMS guidelines: standards for technical reporting in environmental and host-associated microbiome studiesnature.com
253. International consensus statement on microbiome testing in clinical practice - The Lancet Gastroenterology & Hepatologythelancet.com
254. Microbiome research in practice: priorities for clinical translation and impact - ScienceDirectsciencedirect.com
255. Frontiersfrontiersin.org
256. Gut-brain-crosstalk- the vagus nerve and the microbiota-gut-brain axis in depression. A narrative review - ScienceDirectsciencedirect.com
257. Vagus nerve stimulation and gut microbiota interactions: A novel therapeutic avenue for neuropsychiatric disorders - ScienceDirectsciencedirect.com
258. Vagus nerve and brain–gut communication in neurodegenerative diseases: Mechanism and therapeutic perspectives - ScienceDirectsciencedirect.com
259. The role of vagus nerve stimulation in modulating Parkinson’s disease via the microbiota-gut-brain axis: a comprehensive reviewncbi.nlm.nih.gov